Pathway,Celltype,Cor,Enrich_Score,Padj
ADIPOGENESIS,B cells Memory,0.379228084053818,0,> 0.05
ADIPOGENESIS,B cells Naive,-0.256642654439644,NA,> 0.05
ADIPOGENESIS,CAFs MSC iCAF-like,-0.178488417778841,0,> 0.05
ADIPOGENESIS,CAFs myCAF-like,-0.620685142668111,0,> 0.05
ADIPOGENESIS,Cancer Basal SC,0.507676499142053,0,> 0.05
ADIPOGENESIS,Cancer Cycling,0.453511062416465,0,> 0.05
ADIPOGENESIS,Cancer Her2 SC,0.00887220835579698,0,> 0.05
ADIPOGENESIS,Cancer LumA SC,0.188877084672585,NA,> 0.05
ADIPOGENESIS,Cancer LumB SC,0.299494816432072,0,> 0.05
ADIPOGENESIS,Cycling PVL,0.866832029637453,0,> 0.05
ADIPOGENESIS,Cycling T-cells,-0.266679487413657,0,> 0.05
ADIPOGENESIS,Cycling Myeloid,-0.252245173044682,0,NS
ADIPOGENESIS,DCs,0.178622365089428,0,> 0.05
ADIPOGENESIS,Endothelial ACKR1,-0.211085806972875,0,0
ADIPOGENESIS,Endothelial CXCL12,-0.226115651589017,0,0
ADIPOGENESIS,Endothelial Lymphatic LYVE1,-0.194042841991452,0,0
ADIPOGENESIS,Endothelial RGS5,-0.0486159873364535,0,0
ADIPOGENESIS,Luminal Progenitors,-0.229429875443954,0,> 0.05
ADIPOGENESIS,Macrophage,0.344778728124804,0,0
ADIPOGENESIS,Mature Luminal,-0.463829814393707,NA,> 0.05
ADIPOGENESIS,Monocyte,0.227438467613486,0,0
ADIPOGENESIS,Myoepithelial,-0.325552465090208,NA,> 0.05
ADIPOGENESIS,NK cells,0.103676831067197,0,> 0.05
ADIPOGENESIS,NKT cells,0.0119131170542707,0,> 0.05
ADIPOGENESIS,Plasmablasts,0.134742374966039,NA,> 0.05
ADIPOGENESIS,PVL Differentiated,-0.0735198327129359,0,> 0.05
ADIPOGENESIS,PVL Immature,0.148936596684707,0,> 0.05
ADIPOGENESIS,T cells CD4+,-0.0694949100145635,0,> 0.05
ADIPOGENESIS,T cells CD8+,-0.112695659675122,0,> 0.05
ALLOGRAFT REJECTION,B cells Memory,0.0705718564145262,0,> 0.05
ALLOGRAFT REJECTION,B cells Naive,0.052868695252699,NA,> 0.05
ALLOGRAFT REJECTION,CAFs MSC iCAF-like,0.611806408794516,2.81143168447596,4.19327406945509e-17
ALLOGRAFT REJECTION,CAFs myCAF-like,0.558359254773204,2.32646085706781,5.03742955170989e-10
ALLOGRAFT REJECTION,Cancer Basal SC,0.65303854672101,1.95466576585386,4.70601802394794e-06
ALLOGRAFT REJECTION,Cancer Cycling,0.53825436306225,2.28970917381686,4.62596131007618e-10
ALLOGRAFT REJECTION,Cancer Her2 SC,0.599582393505062,0,> 0.05
ALLOGRAFT REJECTION,Cancer LumA SC,0.569072899286568,NA,> 0.05
ALLOGRAFT REJECTION,Cancer LumB SC,0.51265594120804,0,> 0.05
ALLOGRAFT REJECTION,Cycling PVL,0.277863066479251,0,> 0.05
ALLOGRAFT REJECTION,Cycling T-cells,0.246164152212706,0,> 0.05
ALLOGRAFT REJECTION,Cycling Myeloid,0.00476633557696517,0,NS
ALLOGRAFT REJECTION,DCs,0.104937280056692,0,> 0.05
ALLOGRAFT REJECTION,Endothelial ACKR1,-0.109102181988283,0,0
ALLOGRAFT REJECTION,Endothelial CXCL12,-0.137132791305335,0,0
ALLOGRAFT REJECTION,Endothelial Lymphatic LYVE1,0.114375729159305,0,0
ALLOGRAFT REJECTION,Endothelial RGS5,-0.185202479207291,0,0
ALLOGRAFT REJECTION,Luminal Progenitors,-0.0437221182588162,0,> 0.05
ALLOGRAFT REJECTION,Macrophage,0.130762431238162,0,0
ALLOGRAFT REJECTION,Mature Luminal,0.337132266110174,NA,> 0.05
ALLOGRAFT REJECTION,Monocyte,0.0806264145116114,0,0
ALLOGRAFT REJECTION,Myoepithelial,-0.201111674484058,NA,> 0.05
ALLOGRAFT REJECTION,NK cells,0.39469984711491,0,> 0.05
ALLOGRAFT REJECTION,NKT cells,0.348358964153417,0,> 0.05
ALLOGRAFT REJECTION,Plasmablasts,0.125739318386689,NA,> 0.05
ALLOGRAFT REJECTION,PVL Differentiated,0.412434688270313,1.67612525567842,0.000426271456688239
ALLOGRAFT REJECTION,PVL Immature,0.210977587717945,0,> 0.05
ALLOGRAFT REJECTION,T cells CD4+,0.351077639524794,1.56624038046952,0.000254645291481187
ALLOGRAFT REJECTION,T cells CD8+,0.289546820491415,1.36532931240308,0.0456747654422252
ANDROGEN RESPONSE,B cells Memory,0.351623599704612,0,> 0.05
ANDROGEN RESPONSE,B cells Naive,0.333699260168697,NA,> 0.05
ANDROGEN RESPONSE,CAFs MSC iCAF-like,0.411395426603954,1.53380843148403,0.0125344260649185
ANDROGEN RESPONSE,CAFs myCAF-like,0.490659588742797,1.64605738290364,0.00234669525638136
ANDROGEN RESPONSE,Cancer Basal SC,0.122805520120398,0,> 0.05
ANDROGEN RESPONSE,Cancer Cycling,0.115118839012308,0,> 0.05
ANDROGEN RESPONSE,Cancer Her2 SC,-0.0554367737659803,0,> 0.05
ANDROGEN RESPONSE,Cancer LumA SC,-0.182863608590405,NA,> 0.05
ANDROGEN RESPONSE,Cancer LumB SC,-0.0510420794417069,0,> 0.05
ANDROGEN RESPONSE,Cycling PVL,0.505246000362838,0,> 0.05
ANDROGEN RESPONSE,Cycling T-cells,0.108295835623579,0,> 0.05
ANDROGEN RESPONSE,Cycling Myeloid,-0.00372185302203732,0,NS
ANDROGEN RESPONSE,DCs,0.289973741475094,0,> 0.05
ANDROGEN RESPONSE,Endothelial ACKR1,0.168728418922085,0,0
ANDROGEN RESPONSE,Endothelial CXCL12,0.423034191250393,0,0
ANDROGEN RESPONSE,Endothelial Lymphatic LYVE1,-0.156513419517141,0,0
ANDROGEN RESPONSE,Endothelial RGS5,-0.0274962767687286,0,0
ANDROGEN RESPONSE,Luminal Progenitors,-0.267555458031975,0,> 0.05
ANDROGEN RESPONSE,Macrophage,0.184877577069689,0,0
ANDROGEN RESPONSE,Mature Luminal,-0.381592272804745,NA,> 0.05
ANDROGEN RESPONSE,Monocyte,0.246881028076306,0,0
ANDROGEN RESPONSE,Myoepithelial,0.12122975948772,NA,> 0.05
ANDROGEN RESPONSE,NK cells,0.293227711338006,0,> 0.05
ANDROGEN RESPONSE,NKT cells,0.472901126723534,0,> 0.05
ANDROGEN RESPONSE,Plasmablasts,0.172276802198518,NA,> 0.05
ANDROGEN RESPONSE,PVL Differentiated,0.498850752730546,0,> 0.05
ANDROGEN RESPONSE,PVL Immature,0.434871631037577,0,> 0.05
ANDROGEN RESPONSE,T cells CD4+,0.341652763910329,0,> 0.05
ANDROGEN RESPONSE,T cells CD8+,0.258282160159191,0,> 0.05
ANGIOGENESIS,B cells Memory,0.263912783962537,0,> 0.05
ANGIOGENESIS,B cells Naive,-0.0207629732978414,NA,> 0.05
ANGIOGENESIS,CAFs MSC iCAF-like,-0.19349938644029,0,> 0.05
ANGIOGENESIS,CAFs myCAF-like,-0.356690696267887,0,> 0.05
ANGIOGENESIS,Cancer Basal SC,0.485446372891779,2.66495647850718,5.14096407459991e-09
ANGIOGENESIS,Cancer Cycling,0.30994017688334,2.27492439072225,8.34304357265029e-05
ANGIOGENESIS,Cancer Her2 SC,0.48289045363813,2.50197135962777,4.52297021946915e-05
ANGIOGENESIS,Cancer LumA SC,0.193163813817015,NA,> 0.05
ANGIOGENESIS,Cancer LumB SC,0.225332036189231,0,> 0.05
ANGIOGENESIS,Cycling PVL,0.533693660416325,0,> 0.05
ANGIOGENESIS,Cycling T-cells,-0.458625842736019,0,> 0.05
ANGIOGENESIS,Cycling Myeloid,0.302818421816004,0,NS
ANGIOGENESIS,DCs,0.275486097250886,0,> 0.05
ANGIOGENESIS,Endothelial ACKR1,0.729748913964844,0,0
ANGIOGENESIS,Endothelial CXCL12,0.692960826517545,0,0
ANGIOGENESIS,Endothelial Lymphatic LYVE1,-0.23163749833699,0,0
ANGIOGENESIS,Endothelial RGS5,0.504534476179955,0,0
ANGIOGENESIS,Luminal Progenitors,0.478204848939683,0,> 0.05
ANGIOGENESIS,Macrophage,0.314544674865559,0,0
ANGIOGENESIS,Mature Luminal,0.600104700249568,NA,> 0.05
ANGIOGENESIS,Monocyte,0.259407219835157,0,0
ANGIOGENESIS,Myoepithelial,-0.142486581596993,NA,> 0.05
ANGIOGENESIS,NK cells,-0.245387494355071,0,> 0.05
ANGIOGENESIS,NKT cells,-0.470199733044876,0,> 0.05
ANGIOGENESIS,Plasmablasts,-0.0197981273819926,NA,> 0.05
ANGIOGENESIS,PVL Differentiated,0.509256236928837,0,> 0.05
ANGIOGENESIS,PVL Immature,0.460592124072734,0,> 0.05
ANGIOGENESIS,T cells CD4+,-0.235953836279761,0,> 0.05
ANGIOGENESIS,T cells CD8+,-0.396185112371122,0,> 0.05
APICAL JUNCTION,B cells Memory,0.411008045455407,1.48828079583414,0.00321448623849199
APICAL JUNCTION,B cells Naive,-0.399305239203545,NA,> 0.05
APICAL JUNCTION,CAFs MSC iCAF-like,0.521699248978118,1.32115001084298,0.0408109336068469
APICAL JUNCTION,CAFs myCAF-like,0.399503493531703,1.72130243283539,0.00045801080493596
APICAL JUNCTION,Cancer Basal SC,0.544328255465259,2.22158841944423,5.14096407459991e-09
APICAL JUNCTION,Cancer Cycling,0.590251052348192,2.15172753137471,2.06878341313708e-08
APICAL JUNCTION,Cancer Her2 SC,0.248799836461738,1.51293898301469,0.00436550650754794
APICAL JUNCTION,Cancer LumA SC,0.465344033216126,NA,> 0.05
APICAL JUNCTION,Cancer LumB SC,0.488738302011559,0,> 0.05
APICAL JUNCTION,Cycling PVL,0.570005559413313,0,> 0.05
APICAL JUNCTION,Cycling T-cells,0.324387938865799,0,> 0.05
APICAL JUNCTION,Cycling Myeloid,0.437430675764393,0,NS
APICAL JUNCTION,DCs,0.213941368293615,0,> 0.05
APICAL JUNCTION,Endothelial ACKR1,0.648570403601059,0,0
APICAL JUNCTION,Endothelial CXCL12,0.528679459693731,0,0
APICAL JUNCTION,Endothelial Lymphatic LYVE1,-0.146476951200129,0,0
APICAL JUNCTION,Endothelial RGS5,0.641364299634928,0,0
APICAL JUNCTION,Luminal Progenitors,0.0330857615283744,0,> 0.05
APICAL JUNCTION,Macrophage,0.671106627295745,0,0
APICAL JUNCTION,Mature Luminal,-0.269761062727633,NA,> 0.05
APICAL JUNCTION,Monocyte,0.525524333410932,0,0
APICAL JUNCTION,Myoepithelial,-0.312271140398655,NA,> 0.05
APICAL JUNCTION,NK cells,0.373371322227661,0,> 0.05
APICAL JUNCTION,NKT cells,0.411584584136412,0,> 0.05
APICAL JUNCTION,Plasmablasts,-0.312064083386263,NA,> 0.05
APICAL JUNCTION,PVL Differentiated,0.294060869819149,0,> 0.05
APICAL JUNCTION,PVL Immature,0.353717230575174,0,> 0.05
APICAL JUNCTION,T cells CD4+,0.133364124507562,0,> 0.05
APICAL JUNCTION,T cells CD8+,0.238861988396526,0,> 0.05
APICAL SURFACE,B cells Memory,0.374842061367171,0,> 0.05
APICAL SURFACE,B cells Naive,-0.103892587855886,NA,> 0.05
APICAL SURFACE,CAFs MSC iCAF-like,0.464839943132393,0,> 0.05
APICAL SURFACE,CAFs myCAF-like,0.641938678130431,0,> 0.05
APICAL SURFACE,Cancer Basal SC,0.212759920674366,0,> 0.05
APICAL SURFACE,Cancer Cycling,0.091691792092997,0,> 0.05
APICAL SURFACE,Cancer Her2 SC,0.442679417490498,0,> 0.05
APICAL SURFACE,Cancer LumA SC,0.370431818953679,NA,> 0.05
APICAL SURFACE,Cancer LumB SC,-0.144111809313951,0,> 0.05
APICAL SURFACE,Cycling PVL,0.511618031620901,0,> 0.05
APICAL SURFACE,Cycling T-cells,0.294128411425916,0,> 0.05
APICAL SURFACE,Cycling Myeloid,0.251348747792424,0,NS
APICAL SURFACE,DCs,0.336092871916173,0,> 0.05
APICAL SURFACE,Endothelial ACKR1,0.661856330180563,0,0
APICAL SURFACE,Endothelial CXCL12,0.423857075694661,0,0
APICAL SURFACE,Endothelial Lymphatic LYVE1,-0.20122283781787,0,0
APICAL SURFACE,Endothelial RGS5,0.452410187101055,0,0
APICAL SURFACE,Luminal Progenitors,0.409242193710739,0,> 0.05
APICAL SURFACE,Macrophage,0.48755430082246,0,0
APICAL SURFACE,Mature Luminal,-0.269768479706115,NA,> 0.05
APICAL SURFACE,Monocyte,0.248582173829778,0,0
APICAL SURFACE,Myoepithelial,0.217018928333672,NA,> 0.05
APICAL SURFACE,NK cells,0.513508578262382,0,> 0.05
APICAL SURFACE,NKT cells,0.259381877872191,0,> 0.05
APICAL SURFACE,Plasmablasts,-0.186488865492264,NA,> 0.05
APICAL SURFACE,PVL Differentiated,0.296775372605767,0,> 0.05
APICAL SURFACE,PVL Immature,0.53971798974402,0,> 0.05
APICAL SURFACE,T cells CD4+,0.0075045320185239,0,> 0.05
APICAL SURFACE,T cells CD8+,0.28037146894362,0,> 0.05
APOPTOSIS,B cells Memory,0.685836573575879,1.74312963265519,4.1879727662729e-06
APOPTOSIS,B cells Naive,0.510325576739641,NA,> 0.05
APOPTOSIS,CAFs MSC iCAF-like,-0.111478864450695,1.35582406082045,0.02022353925324
APOPTOSIS,CAFs myCAF-like,0.210038645355077,1.75638866593682,0.00063809013484835
APOPTOSIS,Cancer Basal SC,0.574748360491983,1.97389955758997,6.19061500081424e-06
APOPTOSIS,Cancer Cycling,0.559414210558986,1.95565189799711,8.36575491703008e-06
APOPTOSIS,Cancer Her2 SC,0.45327732100897,2.28465026263019,4.24327340129012e-08
APOPTOSIS,Cancer LumA SC,0.497488074132571,NA,> 0.05
APOPTOSIS,Cancer LumB SC,0.419718481123517,1.75433816085204,0.000832402634589726
APOPTOSIS,Cycling PVL,0.450607166681308,0,> 0.05
APOPTOSIS,Cycling T-cells,0.397838353960927,0,> 0.05
APOPTOSIS,Cycling Myeloid,0.233653760512014,0,NS
APOPTOSIS,DCs,0.271543093100534,0,> 0.05
APOPTOSIS,Endothelial ACKR1,-0.0899668357340219,0,0
APOPTOSIS,Endothelial CXCL12,0.101724930049585,0,0
APOPTOSIS,Endothelial Lymphatic LYVE1,-0.413751016537266,0,0
APOPTOSIS,Endothelial RGS5,0.122458142255237,0,0
APOPTOSIS,Luminal Progenitors,-0.0202284903984207,0,> 0.05
APOPTOSIS,Macrophage,0.161723348284179,0,0
APOPTOSIS,Mature Luminal,-0.447502628226757,NA,> 0.05
APOPTOSIS,Monocyte,0.0738554440738705,0,0
APOPTOSIS,Myoepithelial,-0.0911521701377982,NA,> 0.05
APOPTOSIS,NK cells,0.483499059764239,0,> 0.05
APOPTOSIS,NKT cells,0.316531745840901,0,> 0.05
APOPTOSIS,Plasmablasts,0.200804838970343,NA,> 0.05
APOPTOSIS,PVL Differentiated,0.399897547890303,0,> 0.05
APOPTOSIS,PVL Immature,0.191672449705715,0,> 0.05
APOPTOSIS,T cells CD4+,0.595857824648843,1.68774899149978,7.45511162812532e-05
APOPTOSIS,T cells CD8+,0.498155959713378,1.77419634203221,1.82394036509516e-05
BILE ACID METABOLISM,B cells Memory,-0.0586754066020404,0,> 0.05
BILE ACID METABOLISM,B cells Naive,-0.298641696899995,NA,> 0.05
BILE ACID METABOLISM,CAFs MSC iCAF-like,-0.236355316997815,0,> 0.05
BILE ACID METABOLISM,CAFs myCAF-like,-0.507097823443577,0,> 0.05
BILE ACID METABOLISM,Cancer Basal SC,-0.604102483598724,0,> 0.05
BILE ACID METABOLISM,Cancer Cycling,-0.711116917288943,0,> 0.05
BILE ACID METABOLISM,Cancer Her2 SC,-0.549983006000817,0,> 0.05
BILE ACID METABOLISM,Cancer LumA SC,-0.407264381195185,NA,> 0.05
BILE ACID METABOLISM,Cancer LumB SC,-0.542942369920276,0,> 0.05
BILE ACID METABOLISM,Cycling PVL,-0.536708052489491,0,> 0.05
BILE ACID METABOLISM,Cycling T-cells,-0.00495260107432109,0,> 0.05
BILE ACID METABOLISM,Cycling Myeloid,-0.0886536407641867,0,NS
BILE ACID METABOLISM,DCs,0.0673563891424651,0,> 0.05
BILE ACID METABOLISM,Endothelial ACKR1,-0.346237184229423,0,0
BILE ACID METABOLISM,Endothelial CXCL12,-0.456836767126955,0,0
BILE ACID METABOLISM,Endothelial Lymphatic LYVE1,-0.030333577168382,0,0
BILE ACID METABOLISM,Endothelial RGS5,-0.421164350920187,0,0
BILE ACID METABOLISM,Luminal Progenitors,0.515087706274873,0,> 0.05
BILE ACID METABOLISM,Macrophage,0.360637795993226,0,0
BILE ACID METABOLISM,Mature Luminal,-0.0686757136171129,NA,> 0.05
BILE ACID METABOLISM,Monocyte,0.545103388979952,0,0
BILE ACID METABOLISM,Myoepithelial,0.0136065253657045,NA,> 0.05
BILE ACID METABOLISM,NK cells,0.0230719277127146,0,> 0.05
BILE ACID METABOLISM,NKT cells,0.0290400023259931,0,> 0.05
BILE ACID METABOLISM,Plasmablasts,-0.100933947908846,NA,> 0.05
BILE ACID METABOLISM,PVL Differentiated,-0.616393734091867,0,> 0.05
BILE ACID METABOLISM,PVL Immature,-0.384822764062248,0,> 0.05
BILE ACID METABOLISM,T cells CD4+,0.136583185104591,0,> 0.05
BILE ACID METABOLISM,T cells CD8+,-0.0400689282510314,0,> 0.05
CHOLESTEROL HOMEOSTASIS,B cells Memory,0.534932731236918,0,> 0.05
CHOLESTEROL HOMEOSTASIS,B cells Naive,-0.209662121010164,NA,> 0.05
CHOLESTEROL HOMEOSTASIS,CAFs MSC iCAF-like,0.200161385332371,0,> 0.05
CHOLESTEROL HOMEOSTASIS,CAFs myCAF-like,0.636421619417924,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer Basal SC,0.112664016816596,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer Cycling,0.0567366376252518,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer Her2 SC,0.107585273406362,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer LumA SC,0.00990580268320818,NA,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer LumB SC,0.0401002359585527,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cycling PVL,0.384076408184344,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cycling T-cells,0.0859008658846462,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cycling Myeloid,-0.28945919568869,0,NS
CHOLESTEROL HOMEOSTASIS,DCs,0.326328890107735,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Endothelial ACKR1,-0.527138020078456,0,0
CHOLESTEROL HOMEOSTASIS,Endothelial CXCL12,-0.340604760230464,0,0
CHOLESTEROL HOMEOSTASIS,Endothelial Lymphatic LYVE1,-0.55742957603132,0,0
CHOLESTEROL HOMEOSTASIS,Endothelial RGS5,-0.284694484907036,0,0
CHOLESTEROL HOMEOSTASIS,Luminal Progenitors,-0.155390258390406,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Macrophage,0.0847840259252258,0,0
CHOLESTEROL HOMEOSTASIS,Mature Luminal,-0.290731278257871,NA,> 0.05
CHOLESTEROL HOMEOSTASIS,Monocyte,0.279971606875223,0,0
CHOLESTEROL HOMEOSTASIS,Myoepithelial,-0.0327353428717354,NA,> 0.05
CHOLESTEROL HOMEOSTASIS,NK cells,0.430455924106852,0,> 0.05
CHOLESTEROL HOMEOSTASIS,NKT cells,0.390608775635719,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Plasmablasts,-0.1417398237941,NA,> 0.05
CHOLESTEROL HOMEOSTASIS,PVL Differentiated,-0.169792391469521,0,> 0.05
CHOLESTEROL HOMEOSTASIS,PVL Immature,-0.262926657642477,0,> 0.05
CHOLESTEROL HOMEOSTASIS,T cells CD4+,-0.062607002016064,0,> 0.05
CHOLESTEROL HOMEOSTASIS,T cells CD8+,0.0807188352154767,0,> 0.05
COAGULATION,B cells Memory,0.428373179625666,1.88776812691677,3.13975763397147e-06
COAGULATION,B cells Naive,-0.0940332620635122,NA,> 0.05
COAGULATION,CAFs MSC iCAF-like,0.0506362332099385,0,> 0.05
COAGULATION,CAFs myCAF-like,0.455063116899097,1.54746059200516,0.00995165161599896
COAGULATION,Cancer Basal SC,0.531612894294256,2.12697644992192,4.17926312548808e-06
COAGULATION,Cancer Cycling,0.415682466761192,2.34707975190075,2.14283905405306e-08
COAGULATION,Cancer Her2 SC,0.547122202598119,2.50666187328715,3.58870083654908e-08
COAGULATION,Cancer LumA SC,0.342242090965179,NA,> 0.05
COAGULATION,Cancer LumB SC,0.424975061416489,2.23509402086291,1.53728568129804e-05
COAGULATION,Cycling PVL,0.377145395204809,0,> 0.05
COAGULATION,Cycling T-cells,-0.293171797007717,0,> 0.05
COAGULATION,Cycling Myeloid,0.500864734928501,0,NS
COAGULATION,DCs,0.480350176412796,0,> 0.05
COAGULATION,Endothelial ACKR1,0.365216573300609,0,0
COAGULATION,Endothelial CXCL12,0.46912698582858,0,0
COAGULATION,Endothelial Lymphatic LYVE1,-0.308760220514612,0,0
COAGULATION,Endothelial RGS5,0.631155496740058,0,0
COAGULATION,Luminal Progenitors,0.259720821515558,0,> 0.05
COAGULATION,Macrophage,0.316687863871232,0,0
COAGULATION,Mature Luminal,0.0649102817230087,NA,> 0.05
COAGULATION,Monocyte,0.6656042151486,0,0
COAGULATION,Myoepithelial,-0.0827973404656858,NA,> 0.05
COAGULATION,NK cells,-0.205421869685155,0,> 0.05
COAGULATION,NKT cells,0.207962243358108,0,> 0.05
COAGULATION,Plasmablasts,-0.143693127001515,NA,> 0.05
COAGULATION,PVL Differentiated,0.533867396498471,0,> 0.05
COAGULATION,PVL Immature,0.470422331593614,0,> 0.05
COAGULATION,T cells CD4+,-0.199205984104141,0,> 0.05
COAGULATION,T cells CD8+,-0.169916276416733,0,> 0.05
COMPLEMENT,B cells Memory,0.635478670383168,2.11971505820043,9.2514166553005e-14
COMPLEMENT,B cells Naive,-0.175315422795129,NA,> 0.05
COMPLEMENT,CAFs MSC iCAF-like,0.30837116382151,1.82977512642405,1.70230031847997e-05
COMPLEMENT,CAFs myCAF-like,0.491480949558137,1.76470155905019,0.000128606141530485
COMPLEMENT,Cancer Basal SC,0.304685147579145,1.7274714556129,0.000310288627876235
COMPLEMENT,Cancer Cycling,0.254080774091248,2.07530309105549,1.52159619487748e-07
COMPLEMENT,Cancer Her2 SC,0.279707596455923,1.68055923362863,0.000258217432568634
COMPLEMENT,Cancer LumA SC,0.352070501272295,NA,> 0.05
COMPLEMENT,Cancer LumB SC,0.28772818480256,1.504585692888,0.0186374925255856
COMPLEMENT,Cycling PVL,0.294251505244612,0,> 0.05
COMPLEMENT,Cycling T-cells,0.50288033448639,0,> 0.05
COMPLEMENT,Cycling Myeloid,0.652338745260357,0,NS
COMPLEMENT,DCs,0.549204021241557,0,> 0.05
COMPLEMENT,Endothelial ACKR1,0.340963999635925,0,0
COMPLEMENT,Endothelial CXCL12,0.328567117009396,0,0
COMPLEMENT,Endothelial Lymphatic LYVE1,0.0898475556399153,0,0
COMPLEMENT,Endothelial RGS5,0.607244195822774,0,0
COMPLEMENT,Luminal Progenitors,0.281898141534941,0,> 0.05
COMPLEMENT,Macrophage,0.459314624033566,0,0
COMPLEMENT,Mature Luminal,0.181945072550369,NA,> 0.05
COMPLEMENT,Monocyte,0.619665313471914,0,0
COMPLEMENT,Myoepithelial,0.153834153432449,NA,> 0.05
COMPLEMENT,NK cells,0.662393856601111,0,> 0.05
COMPLEMENT,NKT cells,0.752528028001445,0,> 0.05
COMPLEMENT,Plasmablasts,0.103632707585832,NA,> 0.05
COMPLEMENT,PVL Differentiated,0.628571276748301,0,> 0.05
COMPLEMENT,PVL Immature,0.409878972765524,0,> 0.05
COMPLEMENT,T cells CD4+,0.500482761768917,1.4397292400597,0.0045467717380737
COMPLEMENT,T cells CD8+,0.686044042528726,1.70583415754423,4.13128865439261e-05
DNA REPAIR,B cells Memory,-0.0548337351182767,0,> 0.05
DNA REPAIR,B cells Naive,0.00877204698369263,NA,> 0.05
DNA REPAIR,CAFs MSC iCAF-like,0.563414683308792,0,> 0.05
DNA REPAIR,CAFs myCAF-like,0.493528701606954,0,> 0.05
DNA REPAIR,Cancer Basal SC,0.314132502192595,0,> 0.05
DNA REPAIR,Cancer Cycling,0.363784613897069,0,> 0.05
DNA REPAIR,Cancer Her2 SC,-0.0510032964307683,0,> 0.05
DNA REPAIR,Cancer LumA SC,0.025222203336457,NA,> 0.05
DNA REPAIR,Cancer LumB SC,0.228429824374442,0,> 0.05
DNA REPAIR,Cycling PVL,0.794421943345291,0,> 0.05
DNA REPAIR,Cycling T-cells,0.633619706975101,0,> 0.05
DNA REPAIR,Cycling Myeloid,0.492913451948065,0,NS
DNA REPAIR,DCs,0.339464078834111,0,> 0.05
DNA REPAIR,Endothelial ACKR1,0.0402334843333057,0,0
DNA REPAIR,Endothelial CXCL12,-0.0500931056357198,0,0
DNA REPAIR,Endothelial Lymphatic LYVE1,0.183322898409294,0,0
DNA REPAIR,Endothelial RGS5,0.174209843477365,0,0
DNA REPAIR,Luminal Progenitors,-0.26043279736336,0,> 0.05
DNA REPAIR,Macrophage,0.182440718048628,0,0
DNA REPAIR,Mature Luminal,-0.352984468101605,NA,> 0.05
DNA REPAIR,Monocyte,0.240560254422808,0,0
DNA REPAIR,Myoepithelial,-0.292202854081321,NA,> 0.05
DNA REPAIR,NK cells,0.147411394108546,0,> 0.05
DNA REPAIR,NKT cells,0.174972636625408,0,> 0.05
DNA REPAIR,Plasmablasts,-0.047773978686967,NA,> 0.05
DNA REPAIR,PVL Differentiated,-0.156201596904777,0,> 0.05
DNA REPAIR,PVL Immature,0.186095585247336,0,> 0.05
DNA REPAIR,T cells CD4+,0.17919906975696,0,> 0.05
DNA REPAIR,T cells CD8+,0.18663592483122,0,> 0.05
E2F TARGETS,B cells Memory,-0.145648380285695,0,> 0.05
E2F TARGETS,B cells Naive,0.0755581831599703,NA,> 0.05
E2F TARGETS,CAFs MSC iCAF-like,0.49064345101863,2.17850807625692,5.20854760828853e-09
E2F TARGETS,CAFs myCAF-like,-0.00611494666732642,0,> 0.05
E2F TARGETS,Cancer Basal SC,-0.288589717640962,-1.60167988164577,0.000641140078620349
E2F TARGETS,Cancer Cycling,0.462112851272585,0,> 0.05
E2F TARGETS,Cancer Her2 SC,0.0261707941312328,0,> 0.05
E2F TARGETS,Cancer LumA SC,-0.179586707969638,NA,> 0.05
E2F TARGETS,Cancer LumB SC,0.34624643888878,0,> 0.05
E2F TARGETS,Cycling PVL,0.556537377429112,0,> 0.05
E2F TARGETS,Cycling T-cells,0.647250159150642,1.80189981912216,5.60101524459465e-08
E2F TARGETS,Cycling Myeloid,0.446439704527503,0,NS
E2F TARGETS,DCs,0.51899733488516,1.65453018221968,4.44608050895103e-05
E2F TARGETS,Endothelial ACKR1,-0.315909211916281,0,0
E2F TARGETS,Endothelial CXCL12,-0.410726508192037,0,0
E2F TARGETS,Endothelial Lymphatic LYVE1,-0.0380581495815995,0,0
E2F TARGETS,Endothelial RGS5,-0.224624858565152,0,0
E2F TARGETS,Luminal Progenitors,0.300463279799254,0,> 0.05
E2F TARGETS,Macrophage,-0.383592293867952,0,0
E2F TARGETS,Mature Luminal,0.670838152015208,NA,> 0.05
E2F TARGETS,Monocyte,-0.235678625328744,0,0
E2F TARGETS,Myoepithelial,0.584043618640868,NA,> 0.05
E2F TARGETS,NK cells,-0.144827603775611,0,> 0.05
E2F TARGETS,NKT cells,0.0261230851270199,0,> 0.05
E2F TARGETS,Plasmablasts,0.00145053587088255,NA,> 0.05
E2F TARGETS,PVL Differentiated,-0.0869250371777213,0,> 0.05
E2F TARGETS,PVL Immature,-0.295200820435138,0,> 0.05
E2F TARGETS,T cells CD4+,0.0420551221919913,0,> 0.05
E2F TARGETS,T cells CD8+,-0.00980819246365106,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,B cells Memory,0.328983172233644,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,B cells Naive,-0.0628792262949096,NA,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,CAFs MSC iCAF-like,0.106347467697883,1.65107896667734,0.000449815986489812
EPITHELIAL MESENCHYMAL TRANSITION,CAFs myCAF-like,0.239157129731483,1.93201659346194,2.22171661647608e-06
EPITHELIAL MESENCHYMAL TRANSITION,Cancer Basal SC,0.616463854362675,3.4526051971192,3.88066263621259e-42
EPITHELIAL MESENCHYMAL TRANSITION,Cancer Cycling,0.615035995510885,3.51509493983173,2.29871785376691e-39
EPITHELIAL MESENCHYMAL TRANSITION,Cancer Her2 SC,0.639299788506427,4.22591660229075,3.13985281128349e-34
EPITHELIAL MESENCHYMAL TRANSITION,Cancer LumA SC,0.517035873089822,NA,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Cancer LumB SC,0.631338778766878,4.14994778792112,4.32221505694189e-28
EPITHELIAL MESENCHYMAL TRANSITION,Cycling PVL,0.458714199248302,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Cycling T-cells,-0.105425886415177,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Cycling Myeloid,-0.0306030365954909,0,NS
EPITHELIAL MESENCHYMAL TRANSITION,DCs,0.0121310565647623,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Endothelial ACKR1,0.777004875390017,0,0
EPITHELIAL MESENCHYMAL TRANSITION,Endothelial CXCL12,0.819522079296151,0,0
EPITHELIAL MESENCHYMAL TRANSITION,Endothelial Lymphatic LYVE1,-0.261205778639772,0,0
EPITHELIAL MESENCHYMAL TRANSITION,Endothelial RGS5,0.817196619355149,0,0
EPITHELIAL MESENCHYMAL TRANSITION,Luminal Progenitors,0.390996054179128,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Macrophage,0.335426566647631,0,0
EPITHELIAL MESENCHYMAL TRANSITION,Mature Luminal,0.107813646494167,NA,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Monocyte,0.234218209038504,0,0
EPITHELIAL MESENCHYMAL TRANSITION,Myoepithelial,-0.266684145123396,NA,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,NK cells,0.183000030770147,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,NKT cells,0.030965757044814,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Plasmablasts,-0.0700754552250826,NA,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,PVL Differentiated,0.471639388394866,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,PVL Immature,0.37662192911948,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,T cells CD4+,0.0418812097255088,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,T cells CD8+,-0.0154607668011804,0,> 0.05
ESTROGEN RESPONSE EARLY,B cells Memory,0.193609518319409,0,> 0.05
ESTROGEN RESPONSE EARLY,B cells Naive,-0.0306194884689474,NA,> 0.05
ESTROGEN RESPONSE EARLY,CAFs MSC iCAF-like,0.19558500784288,0,> 0.05
ESTROGEN RESPONSE EARLY,CAFs myCAF-like,0.581760934256466,0,> 0.05
ESTROGEN RESPONSE EARLY,Cancer Basal SC,-0.0475130256882877,0,> 0.05
ESTROGEN RESPONSE EARLY,Cancer Cycling,-0.188434751579994,0,> 0.05
ESTROGEN RESPONSE EARLY,Cancer Her2 SC,-0.109077966048797,0,> 0.05
ESTROGEN RESPONSE EARLY,Cancer LumA SC,-0.308540900241357,NA,> 0.05
ESTROGEN RESPONSE EARLY,Cancer LumB SC,-0.482916668176816,0,> 0.05
ESTROGEN RESPONSE EARLY,Cycling PVL,-0.480099615576361,0,> 0.05
ESTROGEN RESPONSE EARLY,Cycling T-cells,-0.130658041190051,0,> 0.05
ESTROGEN RESPONSE EARLY,Cycling Myeloid,-0.234713559797622,0,NS
ESTROGEN RESPONSE EARLY,DCs,0.0978259221871152,0,> 0.05
ESTROGEN RESPONSE EARLY,Endothelial ACKR1,0.0139965878501047,0,0
ESTROGEN RESPONSE EARLY,Endothelial CXCL12,0.0821933937122847,0,0
ESTROGEN RESPONSE EARLY,Endothelial Lymphatic LYVE1,-0.362444540309803,0,0
ESTROGEN RESPONSE EARLY,Endothelial RGS5,0.202790613878544,0,0
ESTROGEN RESPONSE EARLY,Luminal Progenitors,-0.257816934211177,0,> 0.05
ESTROGEN RESPONSE EARLY,Macrophage,-0.175368640134954,0,0
ESTROGEN RESPONSE EARLY,Mature Luminal,-0.536114018334221,NA,> 0.05
ESTROGEN RESPONSE EARLY,Monocyte,0.0103194794450798,0,0
ESTROGEN RESPONSE EARLY,Myoepithelial,0.16556653205199,NA,> 0.05
ESTROGEN RESPONSE EARLY,NK cells,0.51038038323256,0,> 0.05
ESTROGEN RESPONSE EARLY,NKT cells,0.094367851051943,0,> 0.05
ESTROGEN RESPONSE EARLY,Plasmablasts,-0.163514611381283,NA,> 0.05
ESTROGEN RESPONSE EARLY,PVL Differentiated,0.638983000429665,0,> 0.05
ESTROGEN RESPONSE EARLY,PVL Immature,0.590883940520859,0,> 0.05
ESTROGEN RESPONSE EARLY,T cells CD4+,0.230381418634395,0,> 0.05
ESTROGEN RESPONSE EARLY,T cells CD8+,0.15213385572969,0,> 0.05
ESTROGEN RESPONSE LATE,B cells Memory,0.40756433576302,0,> 0.05
ESTROGEN RESPONSE LATE,B cells Naive,-0.110360591424653,NA,> 0.05
ESTROGEN RESPONSE LATE,CAFs MSC iCAF-like,0.242478091113763,1.32434460495558,0.039819476523269
ESTROGEN RESPONSE LATE,CAFs myCAF-like,0.570618200307486,0,> 0.05
ESTROGEN RESPONSE LATE,Cancer Basal SC,-0.0786590918132841,0,> 0.05
ESTROGEN RESPONSE LATE,Cancer Cycling,-0.0924075392324076,0,> 0.05
ESTROGEN RESPONSE LATE,Cancer Her2 SC,-0.227607271652579,0,> 0.05
ESTROGEN RESPONSE LATE,Cancer LumA SC,-0.279677725504641,NA,> 0.05
ESTROGEN RESPONSE LATE,Cancer LumB SC,-0.34024432407212,0,> 0.05
ESTROGEN RESPONSE LATE,Cycling PVL,0.28792978682752,0,> 0.05
ESTROGEN RESPONSE LATE,Cycling T-cells,0.557899754520403,0,> 0.05
ESTROGEN RESPONSE LATE,Cycling Myeloid,0.104078851624744,0,NS
ESTROGEN RESPONSE LATE,DCs,0.42565059643887,0,> 0.05
ESTROGEN RESPONSE LATE,Endothelial ACKR1,-0.222231673856345,0,0
ESTROGEN RESPONSE LATE,Endothelial CXCL12,-0.358101956811052,0,0
ESTROGEN RESPONSE LATE,Endothelial Lymphatic LYVE1,-0.325266711346874,0,0
ESTROGEN RESPONSE LATE,Endothelial RGS5,-0.125424432227238,0,0
ESTROGEN RESPONSE LATE,Luminal Progenitors,-0.0322458457396347,0,> 0.05
ESTROGEN RESPONSE LATE,Macrophage,0.429209403749749,0,0
ESTROGEN RESPONSE LATE,Mature Luminal,-0.527902312937134,NA,> 0.05
ESTROGEN RESPONSE LATE,Monocyte,0.480193208451092,0,0
ESTROGEN RESPONSE LATE,Myoepithelial,-0.0104484924133745,NA,> 0.05
ESTROGEN RESPONSE LATE,NK cells,0.712845009184262,0,> 0.05
ESTROGEN RESPONSE LATE,NKT cells,0.311710764286649,0,> 0.05
ESTROGEN RESPONSE LATE,Plasmablasts,-0.205247250137208,NA,> 0.05
ESTROGEN RESPONSE LATE,PVL Differentiated,0.400239871528605,0,> 0.05
ESTROGEN RESPONSE LATE,PVL Immature,0.296716512556167,0,> 0.05
ESTROGEN RESPONSE LATE,T cells CD4+,0.436900936936634,0,> 0.05
ESTROGEN RESPONSE LATE,T cells CD8+,0.43027481155955,0,> 0.05
FATTY ACID METABOLISM,B cells Memory,0.407127539875171,0,> 0.05
FATTY ACID METABOLISM,B cells Naive,-0.206123994890266,NA,> 0.05
FATTY ACID METABOLISM,CAFs MSC iCAF-like,-0.526732163073998,0,> 0.05
FATTY ACID METABOLISM,CAFs myCAF-like,-0.632755144137942,0,> 0.05
FATTY ACID METABOLISM,Cancer Basal SC,0.394196210183356,0,> 0.05
FATTY ACID METABOLISM,Cancer Cycling,0.452024470901225,0,> 0.05
FATTY ACID METABOLISM,Cancer Her2 SC,-0.0565503326091906,0,> 0.05
FATTY ACID METABOLISM,Cancer LumA SC,0.136991099740912,NA,> 0.05
FATTY ACID METABOLISM,Cancer LumB SC,0.466094890773006,0,> 0.05
FATTY ACID METABOLISM,Cycling PVL,0.84716641160959,0,> 0.05
FATTY ACID METABOLISM,Cycling T-cells,0.449455099675966,0,> 0.05
FATTY ACID METABOLISM,Cycling Myeloid,0.294724494906775,0,NS
FATTY ACID METABOLISM,DCs,0.113194165760786,0,> 0.05
FATTY ACID METABOLISM,Endothelial ACKR1,-0.391027086512726,0,0
FATTY ACID METABOLISM,Endothelial CXCL12,-0.397378516824714,0,0
FATTY ACID METABOLISM,Endothelial Lymphatic LYVE1,-0.34342956182065,0,0
FATTY ACID METABOLISM,Endothelial RGS5,-0.155545342299018,0,0
FATTY ACID METABOLISM,Luminal Progenitors,-0.178622489898975,0,> 0.05
FATTY ACID METABOLISM,Macrophage,0.127594872759609,0,0
FATTY ACID METABOLISM,Mature Luminal,-0.507357941364596,NA,> 0.05
FATTY ACID METABOLISM,Monocyte,0.157086628666479,0,0
FATTY ACID METABOLISM,Myoepithelial,-0.655163140413788,NA,> 0.05
FATTY ACID METABOLISM,NK cells,0.206978537201572,0,> 0.05
FATTY ACID METABOLISM,NKT cells,0.24669233757736,0,> 0.05
FATTY ACID METABOLISM,Plasmablasts,-0.248711097496967,NA,> 0.05
FATTY ACID METABOLISM,PVL Differentiated,-0.368940449913027,0,> 0.05
FATTY ACID METABOLISM,PVL Immature,0.0511108637830333,0,> 0.05
FATTY ACID METABOLISM,T cells CD4+,0.106166287347169,0,> 0.05
FATTY ACID METABOLISM,T cells CD8+,0.0441352743559884,0,> 0.05
G2M CHECKPOINT,B cells Memory,0.0470197755601561,0,> 0.05
G2M CHECKPOINT,B cells Naive,0.134122983934895,NA,> 0.05
G2M CHECKPOINT,CAFs MSC iCAF-like,0.208744395901078,1.50821815718746,0.0055687709472184
G2M CHECKPOINT,CAFs myCAF-like,0.119000530728422,1.45413303848353,0.00995165161599896
G2M CHECKPOINT,Cancer Basal SC,-0.468618595874476,0,> 0.05
G2M CHECKPOINT,Cancer Cycling,0.394764523696176,0,> 0.05
G2M CHECKPOINT,Cancer Her2 SC,-0.0699359953221959,0,> 0.05
G2M CHECKPOINT,Cancer LumA SC,-0.363628253124293,NA,> 0.05
G2M CHECKPOINT,Cancer LumB SC,-0.115921876154282,0,> 0.05
G2M CHECKPOINT,Cycling PVL,0.382306216047746,-1.4788207716775,0.0269850591466217
G2M CHECKPOINT,Cycling T-cells,0.773767219865425,1.71018457867473,9.71175296158779e-07
G2M CHECKPOINT,Cycling Myeloid,0.459581132338068,0,NS
G2M CHECKPOINT,DCs,0.396900925397184,1.71828704724488,4.81209854100508e-06
G2M CHECKPOINT,Endothelial ACKR1,-0.0465512202978813,0,0
G2M CHECKPOINT,Endothelial CXCL12,-0.321943740991429,0,0
G2M CHECKPOINT,Endothelial Lymphatic LYVE1,-0.212076609473391,0,0
G2M CHECKPOINT,Endothelial RGS5,-0.0840354260887258,0,0
G2M CHECKPOINT,Luminal Progenitors,0.0837661017395521,0,> 0.05
G2M CHECKPOINT,Macrophage,-0.250954654322486,0,0
G2M CHECKPOINT,Mature Luminal,0.627856846173297,NA,> 0.05
G2M CHECKPOINT,Monocyte,0.180242930692946,0,0
G2M CHECKPOINT,Myoepithelial,0.702534880220981,NA,> 0.05
G2M CHECKPOINT,NK cells,-0.108410244670627,0,> 0.05
G2M CHECKPOINT,NKT cells,-0.0631200698379418,0,> 0.05
G2M CHECKPOINT,Plasmablasts,0.0155724685817957,NA,> 0.05
G2M CHECKPOINT,PVL Differentiated,0.013005550395864,0,> 0.05
G2M CHECKPOINT,PVL Immature,-0.0577406363241693,0,> 0.05
G2M CHECKPOINT,T cells CD4+,0.301385582650417,1.61953456652028,0.000127425969263474
G2M CHECKPOINT,T cells CD8+,0.163982708970277,1.54274548451572,0.00144972766934564
GLYCOLYSIS,B cells Memory,0.251086826406805,0,> 0.05
GLYCOLYSIS,B cells Naive,-0.398944874843959,NA,> 0.05
GLYCOLYSIS,CAFs MSC iCAF-like,0.088584301375817,0,> 0.05
GLYCOLYSIS,CAFs myCAF-like,0.0253198454662141,0,> 0.05
GLYCOLYSIS,Cancer Basal SC,0.411136873453054,0,> 0.05
GLYCOLYSIS,Cancer Cycling,0.500106966554167,0,> 0.05
GLYCOLYSIS,Cancer Her2 SC,0.00892599345373149,0,> 0.05
GLYCOLYSIS,Cancer LumA SC,0.224604501369256,NA,> 0.05
GLYCOLYSIS,Cancer LumB SC,0.244490716791205,0,> 0.05
GLYCOLYSIS,Cycling PVL,0.574651014893584,0,> 0.05
GLYCOLYSIS,Cycling T-cells,0.166405967973887,0,> 0.05
GLYCOLYSIS,Cycling Myeloid,0.350638520747072,0,NS
GLYCOLYSIS,DCs,0.412630394906831,0,> 0.05
GLYCOLYSIS,Endothelial ACKR1,0.0676913137397793,0,0
GLYCOLYSIS,Endothelial CXCL12,0.775654762974345,0,0
GLYCOLYSIS,Endothelial Lymphatic LYVE1,-0.364995835308896,0,0
GLYCOLYSIS,Endothelial RGS5,0.451663025808955,0,0
GLYCOLYSIS,Luminal Progenitors,-0.113912239044227,0,> 0.05
GLYCOLYSIS,Macrophage,0.258497457691978,0,0
GLYCOLYSIS,Mature Luminal,-0.515035790229928,NA,> 0.05
GLYCOLYSIS,Monocyte,0.291663847027629,0,0
GLYCOLYSIS,Myoepithelial,-0.256885565454679,NA,> 0.05
GLYCOLYSIS,NK cells,0.0324579316423976,0,> 0.05
GLYCOLYSIS,NKT cells,-0.00022856505651286,0,> 0.05
GLYCOLYSIS,Plasmablasts,-0.0663184447487229,NA,> 0.05
GLYCOLYSIS,PVL Differentiated,0.399858267986647,0,> 0.05
GLYCOLYSIS,PVL Immature,0.35924134937138,0,> 0.05
GLYCOLYSIS,T cells CD4+,0.155208651032584,0,> 0.05
GLYCOLYSIS,T cells CD8+,0.0784029400754746,0,> 0.05
HEDGEHOG SIGNALING,B cells Memory,0.441800850738311,0,> 0.05
HEDGEHOG SIGNALING,B cells Naive,-0.019618704315399,NA,> 0.05
HEDGEHOG SIGNALING,CAFs MSC iCAF-like,0.673872333777633,0,> 0.05
HEDGEHOG SIGNALING,CAFs myCAF-like,0.577111745662566,0,> 0.05
HEDGEHOG SIGNALING,Cancer Basal SC,0.410226649555741,0,> 0.05
HEDGEHOG SIGNALING,Cancer Cycling,0.270594195542267,0,> 0.05
HEDGEHOG SIGNALING,Cancer Her2 SC,0.327812179294373,0,> 0.05
HEDGEHOG SIGNALING,Cancer LumA SC,0.0649375559754345,NA,> 0.05
HEDGEHOG SIGNALING,Cancer LumB SC,0.019470862971945,0,> 0.05
HEDGEHOG SIGNALING,Cycling PVL,0.371168960192135,0,> 0.05
HEDGEHOG SIGNALING,Cycling T-cells,0.151827274093428,0,> 0.05
HEDGEHOG SIGNALING,Cycling Myeloid,0.479211577442389,0,NS
HEDGEHOG SIGNALING,DCs,0.050308905818252,0,> 0.05
HEDGEHOG SIGNALING,Endothelial ACKR1,0.677648387915772,0,0
HEDGEHOG SIGNALING,Endothelial CXCL12,0.375199811806207,0,0
HEDGEHOG SIGNALING,Endothelial Lymphatic LYVE1,-0.0980329787633201,0,0
HEDGEHOG SIGNALING,Endothelial RGS5,0.546693133767799,0,0
HEDGEHOG SIGNALING,Luminal Progenitors,0.709845943968523,0,> 0.05
HEDGEHOG SIGNALING,Macrophage,0.788754223494637,0,0
HEDGEHOG SIGNALING,Mature Luminal,0.522029429614943,NA,> 0.05
HEDGEHOG SIGNALING,Monocyte,0.601196488457564,0,0
HEDGEHOG SIGNALING,Myoepithelial,0.430892271208535,NA,> 0.05
HEDGEHOG SIGNALING,NK cells,0.208580525012671,0,> 0.05
HEDGEHOG SIGNALING,NKT cells,0.149741240027079,0,> 0.05
HEDGEHOG SIGNALING,Plasmablasts,-0.0763547511395351,NA,> 0.05
HEDGEHOG SIGNALING,PVL Differentiated,0.469332099066284,0,> 0.05
HEDGEHOG SIGNALING,PVL Immature,0.465680121195095,0,> 0.05
HEDGEHOG SIGNALING,T cells CD4+,-0.15295166414872,0,> 0.05
HEDGEHOG SIGNALING,T cells CD8+,0.366510712001513,0,> 0.05
HEME METABOLISM,B cells Memory,0.573443295661343,1.8564114280318,5.24794574720162e-08
HEME METABOLISM,B cells Naive,0.0888850208714807,NA,> 0.05
HEME METABOLISM,CAFs MSC iCAF-like,0.26987444439174,0,> 0.05
HEME METABOLISM,CAFs myCAF-like,0.404208559209106,0,> 0.05
HEME METABOLISM,Cancer Basal SC,0.217852535785911,0,> 0.05
HEME METABOLISM,Cancer Cycling,-0.17348240464381,0,> 0.05
HEME METABOLISM,Cancer Her2 SC,-0.166679656086201,0,> 0.05
HEME METABOLISM,Cancer LumA SC,-0.0563807570895125,NA,> 0.05
HEME METABOLISM,Cancer LumB SC,-0.0793507226372639,0,> 0.05
HEME METABOLISM,Cycling PVL,-0.0536671130836843,0,> 0.05
HEME METABOLISM,Cycling T-cells,0.0975330573978954,0,> 0.05
HEME METABOLISM,Cycling Myeloid,0.187860159304128,0,NS
HEME METABOLISM,DCs,0.768564013007516,0,> 0.05
HEME METABOLISM,Endothelial ACKR1,0.00378260162794175,0,0
HEME METABOLISM,Endothelial CXCL12,0.180303396327889,0,0
HEME METABOLISM,Endothelial Lymphatic LYVE1,-0.227783343233478,0,0
HEME METABOLISM,Endothelial RGS5,0.0218542673473195,0,0
HEME METABOLISM,Luminal Progenitors,0.225990537341826,0,> 0.05
HEME METABOLISM,Macrophage,0.477320459717553,0,0
HEME METABOLISM,Mature Luminal,-0.344259720264792,NA,> 0.05
HEME METABOLISM,Monocyte,0.736783789958119,0,0
HEME METABOLISM,Myoepithelial,0.384018673082971,NA,> 0.05
HEME METABOLISM,NK cells,0.284956324630802,0,> 0.05
HEME METABOLISM,NKT cells,0.698218628946446,0,> 0.05
HEME METABOLISM,Plasmablasts,0.128652682920064,NA,> 0.05
HEME METABOLISM,PVL Differentiated,-0.0138527986115396,0,> 0.05
HEME METABOLISM,PVL Immature,0.0824856677159147,0,> 0.05
HEME METABOLISM,T cells CD4+,0.626129433464476,1.50176819885836,0.00215762678200175
HEME METABOLISM,T cells CD8+,0.562212873196143,1.60321537459021,0.00123426680554481
HYPOXIA,B cells Memory,0.550377049225964,1.50798962084553,0.00163301035023741
HYPOXIA,B cells Naive,0.148494491332108,NA,> 0.05
HYPOXIA,CAFs MSC iCAF-like,0.0317817512396457,0,> 0.05
HYPOXIA,CAFs myCAF-like,0.0712095602688531,0,> 0.05
HYPOXIA,Cancer Basal SC,0.513237892685119,0,> 0.05
HYPOXIA,Cancer Cycling,0.58531829693495,0,> 0.05
HYPOXIA,Cancer Her2 SC,0.340800327027084,1.55437660612684,0.00109152107584493
HYPOXIA,Cancer LumA SC,0.285246568329282,NA,> 0.05
HYPOXIA,Cancer LumB SC,0.161620436014205,0,> 0.05
HYPOXIA,Cycling PVL,0.620084561201131,0,> 0.05
HYPOXIA,Cycling T-cells,0.367184692008975,0,> 0.05
HYPOXIA,Cycling Myeloid,0.188170172346119,0,NS
HYPOXIA,DCs,0.233660494663881,0,> 0.05
HYPOXIA,Endothelial ACKR1,0.238793642584772,0,0
HYPOXIA,Endothelial CXCL12,0.352822439999239,0,0
HYPOXIA,Endothelial Lymphatic LYVE1,-0.18370825112077,0,0
HYPOXIA,Endothelial RGS5,0.316138326180702,0,0
HYPOXIA,Luminal Progenitors,-0.169629742495888,0,> 0.05
HYPOXIA,Macrophage,0.314684476156276,0,0
HYPOXIA,Mature Luminal,-0.499045017755176,NA,> 0.05
HYPOXIA,Monocyte,0.2357175542903,0,0
HYPOXIA,Myoepithelial,-0.174639308594827,NA,> 0.05
HYPOXIA,NK cells,0.67015161267692,0,> 0.05
HYPOXIA,NKT cells,0.21195460709485,0,> 0.05
HYPOXIA,Plasmablasts,0.127714166479395,NA,> 0.05
HYPOXIA,PVL Differentiated,0.554043634145844,0,> 0.05
HYPOXIA,PVL Immature,0.228723403666252,0,> 0.05
HYPOXIA,T cells CD4+,0.507805627877844,0,> 0.05
HYPOXIA,T cells CD8+,0.375250206211582,0,> 0.05
IL2 STAT5 SIGNALING,B cells Memory,0.449419242942203,1.75250004884295,1.65643771973376e-06
IL2 STAT5 SIGNALING,B cells Naive,-0.311119703285882,NA,> 0.05
IL2 STAT5 SIGNALING,CAFs MSC iCAF-like,0.45040715611991,1.70944603652443,0.000143217600517356
IL2 STAT5 SIGNALING,CAFs myCAF-like,0.69737254235606,1.92421121359898,4.23897569656823e-06
IL2 STAT5 SIGNALING,Cancer Basal SC,0.0246470299707881,2.07284790452785,1.29100015946535e-07
IL2 STAT5 SIGNALING,Cancer Cycling,-0.0762615976317257,1.97507238323291,1.00766069319872e-06
IL2 STAT5 SIGNALING,Cancer Her2 SC,0.0966877460840616,0,> 0.05
IL2 STAT5 SIGNALING,Cancer LumA SC,-0.0917782007632214,NA,> 0.05
IL2 STAT5 SIGNALING,Cancer LumB SC,-0.337356726476305,0,> 0.05
IL2 STAT5 SIGNALING,Cycling PVL,0.0403260447703885,0,> 0.05
IL2 STAT5 SIGNALING,Cycling T-cells,0.27596382939736,0,> 0.05
IL2 STAT5 SIGNALING,Cycling Myeloid,0.242562574670487,0,NS
IL2 STAT5 SIGNALING,DCs,0.255325883071774,0,> 0.05
IL2 STAT5 SIGNALING,Endothelial ACKR1,0.310607175028271,0,0
IL2 STAT5 SIGNALING,Endothelial CXCL12,0.397418930271736,0,0
IL2 STAT5 SIGNALING,Endothelial Lymphatic LYVE1,0.319079996856451,0,0
IL2 STAT5 SIGNALING,Endothelial RGS5,0.236706513331647,0,0
IL2 STAT5 SIGNALING,Luminal Progenitors,0.317223264290125,0,> 0.05
IL2 STAT5 SIGNALING,Macrophage,0.647529560661463,0,0
IL2 STAT5 SIGNALING,Mature Luminal,-0.1154822372875,NA,> 0.05
IL2 STAT5 SIGNALING,Monocyte,0.369999536721476,0,0
IL2 STAT5 SIGNALING,Myoepithelial,0.502590850938944,NA,> 0.05
IL2 STAT5 SIGNALING,NK cells,0.614802388777616,0,> 0.05
IL2 STAT5 SIGNALING,NKT cells,0.629106159850872,0,> 0.05
IL2 STAT5 SIGNALING,Plasmablasts,-0.118802732165206,NA,> 0.05
IL2 STAT5 SIGNALING,PVL Differentiated,0.556814412149032,0,> 0.05
IL2 STAT5 SIGNALING,PVL Immature,0.198462128952869,0,> 0.05
IL2 STAT5 SIGNALING,T cells CD4+,0.598786361680096,1.50584505075389,0.00153411253989518
IL2 STAT5 SIGNALING,T cells CD8+,0.471206555187806,1.47465091198591,0.00503945251562221
IL6 JAK STAT3 SIGNALING,B cells Memory,0.671629336600201,1.97275008087317,1.65643771973376e-06
IL6 JAK STAT3 SIGNALING,B cells Naive,-0.230185717032519,NA,> 0.05
IL6 JAK STAT3 SIGNALING,CAFs MSC iCAF-like,0.590308568442604,2.57237454609471,8.48671162433597e-09
IL6 JAK STAT3 SIGNALING,CAFs myCAF-like,0.545773697169699,2.33879162932069,4.03099929234054e-07
IL6 JAK STAT3 SIGNALING,Cancer Basal SC,-0.113867348705763,2.31393151935048,5.03136954472842e-07
IL6 JAK STAT3 SIGNALING,Cancer Cycling,-0.155414653082297,2.29377669104855,6.14267215400844e-07
IL6 JAK STAT3 SIGNALING,Cancer Her2 SC,0.00167072989561876,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cancer LumA SC,-0.139071018430686,NA,> 0.05
IL6 JAK STAT3 SIGNALING,Cancer LumB SC,-0.222041462304691,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cycling PVL,-0.552475792232377,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cycling T-cells,0.00895909395386857,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cycling Myeloid,0.566094865214264,0,NS
IL6 JAK STAT3 SIGNALING,DCs,0.452494440889861,0,> 0.05
IL6 JAK STAT3 SIGNALING,Endothelial ACKR1,-0.0287354770308131,0,0
IL6 JAK STAT3 SIGNALING,Endothelial CXCL12,-0.00379534281473234,0,0
IL6 JAK STAT3 SIGNALING,Endothelial Lymphatic LYVE1,0.307447762531079,0,0
IL6 JAK STAT3 SIGNALING,Endothelial RGS5,-0.184902672769459,0,0
IL6 JAK STAT3 SIGNALING,Luminal Progenitors,0.499866037122027,1.57713195761755,0.0287030641427892
IL6 JAK STAT3 SIGNALING,Macrophage,0.433453262376179,0,0
IL6 JAK STAT3 SIGNALING,Mature Luminal,0.528898582610363,NA,> 0.05
IL6 JAK STAT3 SIGNALING,Monocyte,0.421330574600205,0,0
IL6 JAK STAT3 SIGNALING,Myoepithelial,0.438351504706828,NA,> 0.05
IL6 JAK STAT3 SIGNALING,NK cells,0.741563683971439,0,> 0.05
IL6 JAK STAT3 SIGNALING,NKT cells,0.346248270527132,0,> 0.05
IL6 JAK STAT3 SIGNALING,Plasmablasts,0.10716982847233,NA,> 0.05
IL6 JAK STAT3 SIGNALING,PVL Differentiated,0.559341409272316,1.8789534054691,0.000127049974500301
IL6 JAK STAT3 SIGNALING,PVL Immature,0.259266185434604,1.5330215436521,0.0383669419415652
IL6 JAK STAT3 SIGNALING,T cells CD4+,0.723929120390346,1.56074450467935,0.00695236286274383
IL6 JAK STAT3 SIGNALING,T cells CD8+,0.828540457887697,1.70416337835165,0.00342718439821683
INFLAMMATORY RESPONSE,B cells Memory,0.616932171805035,2.06849453786656,9.61051717355198e-13
INFLAMMATORY RESPONSE,B cells Naive,0.130592639926366,NA,> 0.05
INFLAMMATORY RESPONSE,CAFs MSC iCAF-like,0.572949592352623,2.75694101400726,3.34594347056338e-16
INFLAMMATORY RESPONSE,CAFs myCAF-like,0.732612935960603,2.50717723734006,2.77948067195898e-12
INFLAMMATORY RESPONSE,Cancer Basal SC,0.0947654005679241,2.35931344368112,1.44744991460503e-11
INFLAMMATORY RESPONSE,Cancer Cycling,0.0173939118590492,2.5559046854822,1.65868028111332e-14
INFLAMMATORY RESPONSE,Cancer Her2 SC,0.20351968783326,1.83960033406635,3.23803360078052e-05
INFLAMMATORY RESPONSE,Cancer LumA SC,0.159506794345381,NA,> 0.05
INFLAMMATORY RESPONSE,Cancer LumB SC,-0.0654833348225188,1.64039723838576,0.00821313291549205
INFLAMMATORY RESPONSE,Cycling PVL,-0.144190113744827,0,> 0.05
INFLAMMATORY RESPONSE,Cycling T-cells,0.296072741303451,0,> 0.05
INFLAMMATORY RESPONSE,Cycling Myeloid,0.555254535016169,0,NS
INFLAMMATORY RESPONSE,DCs,0.309505817156999,0,> 0.05
INFLAMMATORY RESPONSE,Endothelial ACKR1,0.181587138165055,0,0
INFLAMMATORY RESPONSE,Endothelial CXCL12,0.0339137265396811,0,0
INFLAMMATORY RESPONSE,Endothelial Lymphatic LYVE1,0.384743680984877,0,0
INFLAMMATORY RESPONSE,Endothelial RGS5,0.231273301718861,0,0
INFLAMMATORY RESPONSE,Luminal Progenitors,0.635091556507451,0,> 0.05
INFLAMMATORY RESPONSE,Macrophage,0.442010560869911,0,0
INFLAMMATORY RESPONSE,Mature Luminal,0.64082972267626,NA,> 0.05
INFLAMMATORY RESPONSE,Monocyte,0.365165306668423,0,0
INFLAMMATORY RESPONSE,Myoepithelial,0.609370675310457,NA,> 0.05
INFLAMMATORY RESPONSE,NK cells,0.603117048443217,0,> 0.05
INFLAMMATORY RESPONSE,NKT cells,0.220445396419616,0,> 0.05
INFLAMMATORY RESPONSE,Plasmablasts,0.214908599983797,NA,> 0.05
INFLAMMATORY RESPONSE,PVL Differentiated,0.60016066526609,1.85013139691111,3.16413886603503e-06
INFLAMMATORY RESPONSE,PVL Immature,0.306067086162646,0,> 0.05
INFLAMMATORY RESPONSE,T cells CD4+,0.61312877872957,1.73258042816861,1.79624577071319e-06
INFLAMMATORY RESPONSE,T cells CD8+,0.571232064942827,1.61530971883339,0.000414521327631589
INTERFERON ALPHA RESPONSE,B cells Memory,0.280441394795549,1.72785159161825,0.00020532458654302
INTERFERON ALPHA RESPONSE,B cells Naive,0.226752779311587,NA,> 0.05
INTERFERON ALPHA RESPONSE,CAFs MSC iCAF-like,0.626235610306824,2.99204380953228,2.37253601994841e-14
INTERFERON ALPHA RESPONSE,CAFs myCAF-like,0.557928687198958,3.18804359482674,5.24336854339077e-18
INTERFERON ALPHA RESPONSE,Cancer Basal SC,0.345223430578128,2.33842814633883,1.29100015946535e-07
INTERFERON ALPHA RESPONSE,Cancer Cycling,0.269657791269746,2.6755305478576,6.8125964008478e-11
INTERFERON ALPHA RESPONSE,Cancer Her2 SC,0.383652054940874,2.04518847661447,3.27091975545325e-05
INTERFERON ALPHA RESPONSE,Cancer LumA SC,0.518128071257066,NA,> 0.05
INTERFERON ALPHA RESPONSE,Cancer LumB SC,0.206009101369138,0,> 0.05
INTERFERON ALPHA RESPONSE,Cycling PVL,0.247987889754586,0,> 0.05
INTERFERON ALPHA RESPONSE,Cycling T-cells,0.671047746367577,2.00579893152207,3.45914128839701e-07
INTERFERON ALPHA RESPONSE,Cycling Myeloid,0.280888744761115,0,NS
INTERFERON ALPHA RESPONSE,DCs,0.350114839773115,0,> 0.05
INTERFERON ALPHA RESPONSE,Endothelial ACKR1,-0.182133234743991,0,0
INTERFERON ALPHA RESPONSE,Endothelial CXCL12,0.139556491666506,0,0
INTERFERON ALPHA RESPONSE,Endothelial Lymphatic LYVE1,0.215183981494324,0,0
INTERFERON ALPHA RESPONSE,Endothelial RGS5,-0.178264925680031,0,0
INTERFERON ALPHA RESPONSE,Luminal Progenitors,0.29418600607167,3.09014433414862,3.16278188645477e-15
INTERFERON ALPHA RESPONSE,Macrophage,0.383430712324438,0,0
INTERFERON ALPHA RESPONSE,Mature Luminal,0.388027197295612,NA,> 0.05
INTERFERON ALPHA RESPONSE,Monocyte,0.445313696097566,0,0
INTERFERON ALPHA RESPONSE,Myoepithelial,0.081352970548253,NA,> 0.05
INTERFERON ALPHA RESPONSE,NK cells,0.677754287312145,1.89308998323086,1.58643623072676e-06
INTERFERON ALPHA RESPONSE,NKT cells,0.827498891413286,0,> 0.05
INTERFERON ALPHA RESPONSE,Plasmablasts,0.345920589063566,NA,> 0.05
INTERFERON ALPHA RESPONSE,PVL Differentiated,0.615336213513958,2.41753564670199,2.1456528187089e-12
INTERFERON ALPHA RESPONSE,PVL Immature,0.356457637958553,1.76085634946895,0.00112968797738044
INTERFERON ALPHA RESPONSE,T cells CD4+,0.766373442887514,2.42416700104118,1.21352503605858e-15
INTERFERON ALPHA RESPONSE,T cells CD8+,0.812189847380704,2.54200790773127,3.44148050703653e-16
INTERFERON GAMMA RESPONSE,B cells Memory,0.382730708104738,1.93160158287128,1.46336619324107e-10
INTERFERON GAMMA RESPONSE,B cells Naive,0.153814051572284,NA,> 0.05
INTERFERON GAMMA RESPONSE,CAFs MSC iCAF-like,0.61168711264007,3.18901547889593,2.59017605075115e-25
INTERFERON GAMMA RESPONSE,CAFs myCAF-like,0.569144309051286,3.26743614206423,8.28939566233416e-28
INTERFERON GAMMA RESPONSE,Cancer Basal SC,0.391765414981492,2.43243539586086,1.03949567070379e-12
INTERFERON GAMMA RESPONSE,Cancer Cycling,0.331058690893991,2.65630013091357,5.35403187120546e-16
INTERFERON GAMMA RESPONSE,Cancer Her2 SC,0.398047525107324,1.85112912156713,2.43133871412299e-05
INTERFERON GAMMA RESPONSE,Cancer LumA SC,0.475375607853349,NA,> 0.05
INTERFERON GAMMA RESPONSE,Cancer LumB SC,0.289999798387375,0,> 0.05
INTERFERON GAMMA RESPONSE,Cycling PVL,0.220918509680463,0,> 0.05
INTERFERON GAMMA RESPONSE,Cycling T-cells,0.674959590208515,1.80322358281708,5.60101524459465e-08
INTERFERON GAMMA RESPONSE,Cycling Myeloid,0.47744005791396,0,NS
INTERFERON GAMMA RESPONSE,DCs,0.476054571884675,0,> 0.05
INTERFERON GAMMA RESPONSE,Endothelial ACKR1,-0.116131228493799,0,0
INTERFERON GAMMA RESPONSE,Endothelial CXCL12,0.171359125452773,0,0
INTERFERON GAMMA RESPONSE,Endothelial Lymphatic LYVE1,0.13685166431599,0,0
INTERFERON GAMMA RESPONSE,Endothelial RGS5,-0.0169236855781284,0,0
INTERFERON GAMMA RESPONSE,Luminal Progenitors,0.305423299904377,0,> 0.05
INTERFERON GAMMA RESPONSE,Macrophage,0.459616238599403,0,0
INTERFERON GAMMA RESPONSE,Mature Luminal,0.458034845442947,NA,> 0.05
INTERFERON GAMMA RESPONSE,Monocyte,0.461156420752598,0,0
INTERFERON GAMMA RESPONSE,Myoepithelial,0.13217858997736,NA,> 0.05
INTERFERON GAMMA RESPONSE,NK cells,0.819290765380918,1.69327153976354,1.58643623072676e-06
INTERFERON GAMMA RESPONSE,NKT cells,0.71118170854575,1.64764541216173,0.000127624509415874
INTERFERON GAMMA RESPONSE,Plasmablasts,0.30746106759031,NA,> 0.05
INTERFERON GAMMA RESPONSE,PVL Differentiated,0.667187630174764,2.20694518198011,4.90000924759837e-14
INTERFERON GAMMA RESPONSE,PVL Immature,0.395245372848349,1.79730170529215,2.92176644567252e-06
INTERFERON GAMMA RESPONSE,T cells CD4+,0.840146147446763,2.47044131249217,2.25941036139718e-28
INTERFERON GAMMA RESPONSE,T cells CD8+,0.781661854503689,2.45958291543276,4.39910245597497e-23
KRAS SIGNALING DN,B cells Memory,0.029122668046822,0,> 0.05
KRAS SIGNALING DN,B cells Naive,0.530056256418047,NA,> 0.05
KRAS SIGNALING DN,CAFs MSC iCAF-like,0.504976002355009,0,> 0.05
KRAS SIGNALING DN,CAFs myCAF-like,0.280395017782039,0,> 0.05
KRAS SIGNALING DN,Cancer Basal SC,-0.506646729019857,0,> 0.05
KRAS SIGNALING DN,Cancer Cycling,-0.641676846423464,0,> 0.05
KRAS SIGNALING DN,Cancer Her2 SC,-0.0863993279750432,0,> 0.05
KRAS SIGNALING DN,Cancer LumA SC,-0.445587584321892,NA,> 0.05
KRAS SIGNALING DN,Cancer LumB SC,-0.344598279577251,0,> 0.05
KRAS SIGNALING DN,Cycling PVL,-0.519117596215685,0,> 0.05
KRAS SIGNALING DN,Cycling T-cells,0.191295140572521,0,> 0.05
KRAS SIGNALING DN,Cycling Myeloid,-0.599878350069124,0,NS
KRAS SIGNALING DN,DCs,0.00139087889445398,0,> 0.05
KRAS SIGNALING DN,Endothelial ACKR1,-0.360170845162289,0,0
KRAS SIGNALING DN,Endothelial CXCL12,-0.504246702922884,0,0
KRAS SIGNALING DN,Endothelial Lymphatic LYVE1,-0.0556114203980961,0,0
KRAS SIGNALING DN,Endothelial RGS5,-0.570599494950518,0,0
KRAS SIGNALING DN,Luminal Progenitors,-0.318895791555824,0,> 0.05
KRAS SIGNALING DN,Macrophage,-0.438593667874329,0,0
KRAS SIGNALING DN,Mature Luminal,0.104293399926953,NA,> 0.05
KRAS SIGNALING DN,Monocyte,-0.203356422216565,0,0
KRAS SIGNALING DN,Myoepithelial,0.0579498566715111,NA,> 0.05
KRAS SIGNALING DN,NK cells,0.464969962472428,0,> 0.05
KRAS SIGNALING DN,NKT cells,0.157615504303609,0,> 0.05
KRAS SIGNALING DN,Plasmablasts,0.212260866573789,NA,> 0.05
KRAS SIGNALING DN,PVL Differentiated,-0.0473101838838587,0,> 0.05
KRAS SIGNALING DN,PVL Immature,-0.0514665046085268,0,> 0.05
KRAS SIGNALING DN,T cells CD4+,0.219312219785987,0,> 0.05
KRAS SIGNALING DN,T cells CD8+,0.184545742973541,0,> 0.05
KRAS SIGNALING UP,B cells Memory,0.561615838362635,1.73693924438217,3.50947691106902e-06
KRAS SIGNALING UP,B cells Naive,-0.365281960603124,NA,> 0.05
KRAS SIGNALING UP,CAFs MSC iCAF-like,0.0327716841562318,0,> 0.05
KRAS SIGNALING UP,CAFs myCAF-like,-0.00338679806430893,1.57517513187446,0.00186196548238423
KRAS SIGNALING UP,Cancer Basal SC,-0.378015020497708,1.83150139720671,3.89302087083345e-05
KRAS SIGNALING UP,Cancer Cycling,-0.413046448406537,2.01017971292762,7.30183330352761e-07
KRAS SIGNALING UP,Cancer Her2 SC,-0.112404258723477,1.59924960389065,0.000872116254658489
KRAS SIGNALING UP,Cancer LumA SC,-0.216669475775505,NA,> 0.05
KRAS SIGNALING UP,Cancer LumB SC,-0.363477557931266,1.50683498080383,0.0186374925255856
KRAS SIGNALING UP,Cycling PVL,-0.448985698022964,0,> 0.05
KRAS SIGNALING UP,Cycling T-cells,-0.2709366578966,0,> 0.05
KRAS SIGNALING UP,Cycling Myeloid,0.205267883960172,0,NS
KRAS SIGNALING UP,DCs,-0.0434117302164677,0,> 0.05
KRAS SIGNALING UP,Endothelial ACKR1,0.101528651511122,0,0
KRAS SIGNALING UP,Endothelial CXCL12,0.473084293826437,0,0
KRAS SIGNALING UP,Endothelial Lymphatic LYVE1,0.265597966789256,0,0
KRAS SIGNALING UP,Endothelial RGS5,-0.0534137658892527,0,0
KRAS SIGNALING UP,Luminal Progenitors,0.518571108362137,0,> 0.05
KRAS SIGNALING UP,Macrophage,0.440692137500619,0,0
KRAS SIGNALING UP,Mature Luminal,0.582222629802002,NA,> 0.05
KRAS SIGNALING UP,Monocyte,0.210003405697177,0,0
KRAS SIGNALING UP,Myoepithelial,0.718388785428261,NA,> 0.05
KRAS SIGNALING UP,NK cells,0.383742832995567,0,> 0.05
KRAS SIGNALING UP,NKT cells,0.119754201227179,0,> 0.05
KRAS SIGNALING UP,Plasmablasts,0.0640396511680742,NA,> 0.05
KRAS SIGNALING UP,PVL Differentiated,0.565473800274097,0,> 0.05
KRAS SIGNALING UP,PVL Immature,0.0184800223709427,0,> 0.05
KRAS SIGNALING UP,T cells CD4+,0.269094837606939,0,> 0.05
KRAS SIGNALING UP,T cells CD8+,0.293262684809173,0,> 0.05
MITOTIC SPINDLE,B cells Memory,0.0727402015459827,1.7174757234505,1.75332891469777e-06
MITOTIC SPINDLE,B cells Naive,0.0035300261511436,NA,> 0.05
MITOTIC SPINDLE,CAFs MSC iCAF-like,0.392171550542366,0,> 0.05
MITOTIC SPINDLE,CAFs myCAF-like,0.425809779346857,1.56696375240812,0.00174464107549111
MITOTIC SPINDLE,Cancer Basal SC,-0.400836307064399,0,> 0.05
MITOTIC SPINDLE,Cancer Cycling,0.0135933455178609,0,> 0.05
MITOTIC SPINDLE,Cancer Her2 SC,-0.380493201620947,0,> 0.05
MITOTIC SPINDLE,Cancer LumA SC,-0.232051764653949,NA,> 0.05
MITOTIC SPINDLE,Cancer LumB SC,-0.483668691529928,0,> 0.05
MITOTIC SPINDLE,Cycling PVL,0.190769180443692,0,> 0.05
MITOTIC SPINDLE,Cycling T-cells,0.744253212006419,1.73274023558652,9.71175296158779e-07
MITOTIC SPINDLE,Cycling Myeloid,0.368750536790994,0,NS
MITOTIC SPINDLE,DCs,0.611075292226824,0,> 0.05
MITOTIC SPINDLE,Endothelial ACKR1,0.655462995770064,0,0
MITOTIC SPINDLE,Endothelial CXCL12,0.518598631902227,0,0
MITOTIC SPINDLE,Endothelial Lymphatic LYVE1,-0.51769231840689,0,0
MITOTIC SPINDLE,Endothelial RGS5,0.509228329245645,0,0
MITOTIC SPINDLE,Luminal Progenitors,0.27258092508083,0,> 0.05
MITOTIC SPINDLE,Macrophage,0.240923778390473,0,0
MITOTIC SPINDLE,Mature Luminal,0.482135558494554,NA,> 0.05
MITOTIC SPINDLE,Monocyte,-0.0372459202821118,0,0
MITOTIC SPINDLE,Myoepithelial,0.184282008081399,NA,> 0.05
MITOTIC SPINDLE,NK cells,-0.107412468486702,0,> 0.05
MITOTIC SPINDLE,NKT cells,0.29744686883566,0,> 0.05
MITOTIC SPINDLE,Plasmablasts,-0.0492347137717313,NA,> 0.05
MITOTIC SPINDLE,PVL Differentiated,-0.0881832417313956,0,> 0.05
MITOTIC SPINDLE,PVL Immature,0.207348780116511,0,> 0.05
MITOTIC SPINDLE,T cells CD4+,-0.0081012108089891,1.66009203990622,1.69937604221957e-05
MITOTIC SPINDLE,T cells CD8+,0.222082814544014,1.82518878440482,7.53709962026374e-07
MTORC1 SIGNALING,B cells Memory,0.401319506210177,0,> 0.05
MTORC1 SIGNALING,B cells Naive,0.00512264996087867,NA,> 0.05
MTORC1 SIGNALING,CAFs MSC iCAF-like,0.549489420371186,1.759599464082,3.41751849887863e-05
MTORC1 SIGNALING,CAFs myCAF-like,0.539589245759134,2.17345018685251,9.44065377504699e-09
MTORC1 SIGNALING,Cancer Basal SC,0.402783454171743,0,> 0.05
MTORC1 SIGNALING,Cancer Cycling,0.565118665814465,0,> 0.05
MTORC1 SIGNALING,Cancer Her2 SC,0.146888690694606,0,> 0.05
MTORC1 SIGNALING,Cancer LumA SC,0.137139274542945,NA,> 0.05
MTORC1 SIGNALING,Cancer LumB SC,0.279832212295519,0,> 0.05
MTORC1 SIGNALING,Cycling PVL,0.654747486396567,0,> 0.05
MTORC1 SIGNALING,Cycling T-cells,0.563817530156436,0,> 0.05
MTORC1 SIGNALING,Cycling Myeloid,0.0871911047031988,0,NS
MTORC1 SIGNALING,DCs,0.42478625813907,0,> 0.05
MTORC1 SIGNALING,Endothelial ACKR1,0.177947851608486,0,0
MTORC1 SIGNALING,Endothelial CXCL12,0.46165354349895,0,0
MTORC1 SIGNALING,Endothelial Lymphatic LYVE1,-0.0878349379659327,0,0
MTORC1 SIGNALING,Endothelial RGS5,0.296677808426224,0,0
MTORC1 SIGNALING,Luminal Progenitors,-0.17262881429072,0,> 0.05
MTORC1 SIGNALING,Macrophage,0.138951032883225,0,0
MTORC1 SIGNALING,Mature Luminal,-0.363928642307085,NA,> 0.05
MTORC1 SIGNALING,Monocyte,0.338966201596206,0,0
MTORC1 SIGNALING,Myoepithelial,-0.222287664691551,NA,> 0.05
MTORC1 SIGNALING,NK cells,0.579131138422507,0,> 0.05
MTORC1 SIGNALING,NKT cells,0.485688679197075,0,> 0.05
MTORC1 SIGNALING,Plasmablasts,0.054755406949046,NA,> 0.05
MTORC1 SIGNALING,PVL Differentiated,0.273042101180806,0,> 0.05
MTORC1 SIGNALING,PVL Immature,0.351216805776488,1.42832757917043,0.0239596561471359
MTORC1 SIGNALING,T cells CD4+,0.453388739982671,1.73019064049491,2.03456333085827e-06
MTORC1 SIGNALING,T cells CD8+,0.385963745009389,1.68358460995042,8.40277609128972e-05
MYC TARGETS V1,B cells Memory,-0.048816559298925,0,> 0.05
MYC TARGETS V1,B cells Naive,0.147509606586758,NA,> 0.05
MYC TARGETS V1,CAFs MSC iCAF-like,-0.137020130521216,1.35384197986367,0.0246398631481595
MYC TARGETS V1,CAFs myCAF-like,-0.0357429397438271,1.52924771204551,0.00337145580391659
MYC TARGETS V1,Cancer Basal SC,0.487431515889586,-1.35582113817095,0.0167708258064995
MYC TARGETS V1,Cancer Cycling,0.55037986888541,0,> 0.05
MYC TARGETS V1,Cancer Her2 SC,0.266031354898099,1.54245881914932,0.00107997024492347
MYC TARGETS V1,Cancer LumA SC,0.279993732290207,NA,> 0.05
MYC TARGETS V1,Cancer LumB SC,0.62236701913747,2.43240703499209,2.24031021762163e-08
MYC TARGETS V1,Cycling PVL,0.707280287031437,0,> 0.05
MYC TARGETS V1,Cycling T-cells,0.297132443831991,0,> 0.05
MYC TARGETS V1,Cycling Myeloid,0.158138864288622,0,NS
MYC TARGETS V1,DCs,0.120977605256969,0,> 0.05
MYC TARGETS V1,Endothelial ACKR1,-0.00148058507089532,0,0
MYC TARGETS V1,Endothelial CXCL12,-0.0164977368089222,0,0
MYC TARGETS V1,Endothelial Lymphatic LYVE1,-0.00515829747259127,0,0
MYC TARGETS V1,Endothelial RGS5,0.250019234258554,0,0
MYC TARGETS V1,Luminal Progenitors,-0.470824718655799,0,> 0.05
MYC TARGETS V1,Macrophage,-0.0421646817162038,0,0
MYC TARGETS V1,Mature Luminal,-0.345966259989169,NA,> 0.05
MYC TARGETS V1,Monocyte,-0.0316772449607715,0,0
MYC TARGETS V1,Myoepithelial,-0.321314394105091,NA,> 0.05
MYC TARGETS V1,NK cells,0.113171918738203,0,> 0.05
MYC TARGETS V1,NKT cells,0.288700980189149,0,> 0.05
MYC TARGETS V1,Plasmablasts,0.12642529193717,NA,> 0.05
MYC TARGETS V1,PVL Differentiated,-0.058859285221164,0,> 0.05
MYC TARGETS V1,PVL Immature,0.13083391262709,0,> 0.05
MYC TARGETS V1,T cells CD4+,0.17721393255559,0,> 0.05
MYC TARGETS V1,T cells CD8+,0.158545521891195,0,> 0.05
MYC TARGETS V2,B cells Memory,-0.408867880100166,0,> 0.05
MYC TARGETS V2,B cells Naive,-0.245028899850484,NA,> 0.05
MYC TARGETS V2,CAFs MSC iCAF-like,0.0579204953316829,0,> 0.05
MYC TARGETS V2,CAFs myCAF-like,-0.211643536989506,0,> 0.05
MYC TARGETS V2,Cancer Basal SC,-0.0191044306280269,0,> 0.05
MYC TARGETS V2,Cancer Cycling,0.444134529881285,0,> 0.05
MYC TARGETS V2,Cancer Her2 SC,-0.0890678461522799,0,> 0.05
MYC TARGETS V2,Cancer LumA SC,-0.0103455005197006,NA,> 0.05
MYC TARGETS V2,Cancer LumB SC,0.401291429630822,0,> 0.05
MYC TARGETS V2,Cycling PVL,0.366357812597353,0,> 0.05
MYC TARGETS V2,Cycling T-cells,-0.23070341833554,0,> 0.05
MYC TARGETS V2,Cycling Myeloid,-0.465298731344252,0,NS
MYC TARGETS V2,DCs,-0.384203559173915,0,> 0.05
MYC TARGETS V2,Endothelial ACKR1,-0.36465531021436,0,0
MYC TARGETS V2,Endothelial CXCL12,-0.276300218277297,0,0
MYC TARGETS V2,Endothelial Lymphatic LYVE1,0.666107387865462,0,0
MYC TARGETS V2,Endothelial RGS5,-0.237037863250747,0,0
MYC TARGETS V2,Luminal Progenitors,-0.469146484297713,0,> 0.05
MYC TARGETS V2,Macrophage,-0.660912594426879,0,0
MYC TARGETS V2,Mature Luminal,0.699844152119407,NA,> 0.05
MYC TARGETS V2,Monocyte,-0.187480797973248,0,0
MYC TARGETS V2,Myoepithelial,0.471414022174381,NA,> 0.05
MYC TARGETS V2,NK cells,-0.0496995712371862,0,> 0.05
MYC TARGETS V2,NKT cells,-0.0822648463569845,0,> 0.05
MYC TARGETS V2,Plasmablasts,-0.186414278566903,NA,> 0.05
MYC TARGETS V2,PVL Differentiated,-0.367264666586592,0,> 0.05
MYC TARGETS V2,PVL Immature,-0.5813178096544,0,> 0.05
MYC TARGETS V2,T cells CD4+,0.122926129660284,0,> 0.05
MYC TARGETS V2,T cells CD8+,-0.0212759684829157,0,> 0.05
MYOGENESIS,B cells Memory,0.119026794119566,0,> 0.05
MYOGENESIS,B cells Naive,-0.221238570507593,NA,> 0.05
MYOGENESIS,CAFs MSC iCAF-like,-0.268752528155621,0,> 0.05
MYOGENESIS,CAFs myCAF-like,-0.202463706870155,0,> 0.05
MYOGENESIS,Cancer Basal SC,0.452429192916095,2.13451603062033,1.29100015946535e-07
MYOGENESIS,Cancer Cycling,0.221408961673105,1.65885799240066,0.00100571073554778
MYOGENESIS,Cancer Her2 SC,0.376022761644443,0,> 0.05
MYOGENESIS,Cancer LumA SC,0.328337320218185,NA,> 0.05
MYOGENESIS,Cancer LumB SC,-0.14966884080962,0,> 0.05
MYOGENESIS,Cycling PVL,0.595800623025192,0,> 0.05
MYOGENESIS,Cycling T-cells,-0.258037611637124,0,> 0.05
MYOGENESIS,Cycling Myeloid,0.137318456037725,0,NS
MYOGENESIS,DCs,-0.0751903403076315,0,> 0.05
MYOGENESIS,Endothelial ACKR1,0.242791009594221,0,0
MYOGENESIS,Endothelial CXCL12,0.428253704462732,0,0
MYOGENESIS,Endothelial Lymphatic LYVE1,-0.275386421128584,0,0
MYOGENESIS,Endothelial RGS5,0.443455398902336,0,0
MYOGENESIS,Luminal Progenitors,0.18595116540315,0,> 0.05
MYOGENESIS,Macrophage,0.328172210960354,0,0
MYOGENESIS,Mature Luminal,-0.0237741642775039,NA,> 0.05
MYOGENESIS,Monocyte,0.28094595185289,0,0
MYOGENESIS,Myoepithelial,-0.369569427284801,NA,> 0.05
MYOGENESIS,NK cells,-0.0953293710814225,0,> 0.05
MYOGENESIS,NKT cells,-0.017182174036628,0,> 0.05
MYOGENESIS,Plasmablasts,-0.201079756160719,NA,> 0.05
MYOGENESIS,PVL Differentiated,0.240360053161734,0,> 0.05
MYOGENESIS,PVL Immature,0.305506087308554,0,> 0.05
MYOGENESIS,T cells CD4+,-0.0983063150773135,0,> 0.05
MYOGENESIS,T cells CD8+,-0.122166355006565,0,> 0.05
NOTCH SIGNALING,B cells Memory,-0.00205253696571287,0,> 0.05
NOTCH SIGNALING,B cells Naive,0.017860570313395,NA,> 0.05
NOTCH SIGNALING,CAFs MSC iCAF-like,-0.705401281604718,0,> 0.05
NOTCH SIGNALING,CAFs myCAF-like,-0.702050504613918,0,> 0.05
NOTCH SIGNALING,Cancer Basal SC,-0.0529466279816654,0,> 0.05
NOTCH SIGNALING,Cancer Cycling,-0.238216026501566,0,> 0.05
NOTCH SIGNALING,Cancer Her2 SC,-0.148591514880958,0,> 0.05
NOTCH SIGNALING,Cancer LumA SC,0.000231551043246418,NA,> 0.05
NOTCH SIGNALING,Cancer LumB SC,-0.393877954324476,0,> 0.05
NOTCH SIGNALING,Cycling PVL,0.463533183331388,0,> 0.05
NOTCH SIGNALING,Cycling T-cells,-0.578630807200904,0,> 0.05
NOTCH SIGNALING,Cycling Myeloid,-0.568423004858639,0,NS
NOTCH SIGNALING,DCs,-0.213449124051834,0,> 0.05
NOTCH SIGNALING,Endothelial ACKR1,0.00726007316246739,0,0
NOTCH SIGNALING,Endothelial CXCL12,0.000860234027807293,0,0
NOTCH SIGNALING,Endothelial Lymphatic LYVE1,-0.157544930156382,0,0
NOTCH SIGNALING,Endothelial RGS5,0.0273601144907219,0,0
NOTCH SIGNALING,Luminal Progenitors,0.126941810533488,0,> 0.05
NOTCH SIGNALING,Macrophage,-0.289866996356379,0,0
NOTCH SIGNALING,Mature Luminal,-0.230242589039214,NA,> 0.05
NOTCH SIGNALING,Monocyte,-0.198879887245979,0,0
NOTCH SIGNALING,Myoepithelial,0.505978567752068,NA,> 0.05
NOTCH SIGNALING,NK cells,0.326767216948435,0,> 0.05
NOTCH SIGNALING,NKT cells,-0.253643413464573,0,> 0.05
NOTCH SIGNALING,Plasmablasts,0.00231731141153334,NA,> 0.05
NOTCH SIGNALING,PVL Differentiated,0.0223376790257109,0,> 0.05
NOTCH SIGNALING,PVL Immature,-0.188028822336811,0,> 0.05
NOTCH SIGNALING,T cells CD4+,-0.214170394653189,0,> 0.05
NOTCH SIGNALING,T cells CD8+,-0.177341137659906,0,> 0.05
OXIDATIVE PHOSPHORYLATION,B cells Memory,0.222151797835146,1.58771787045003,0.00024802012191476
OXIDATIVE PHOSPHORYLATION,B cells Naive,-0.301746883357123,NA,> 0.05
OXIDATIVE PHOSPHORYLATION,CAFs MSC iCAF-like,0.0284243477911511,0,> 0.05
OXIDATIVE PHOSPHORYLATION,CAFs myCAF-like,-0.188620762513346,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Cancer Basal SC,0.381498272999457,-1.58848263012193,0.00104166678814965
OXIDATIVE PHOSPHORYLATION,Cancer Cycling,0.356494361445746,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Cancer Her2 SC,-0.0019431246363259,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Cancer LumA SC,0.168085645720791,NA,> 0.05
OXIDATIVE PHOSPHORYLATION,Cancer LumB SC,0.409873780337484,2.03595641616927,1.53728568129804e-05
OXIDATIVE PHOSPHORYLATION,Cycling PVL,0.731304412816622,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Cycling T-cells,0.183508371744079,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Cycling Myeloid,-0.0241455588384982,0,NS
OXIDATIVE PHOSPHORYLATION,DCs,0.251160525383658,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Endothelial ACKR1,0.0927806080847158,0,0
OXIDATIVE PHOSPHORYLATION,Endothelial CXCL12,0.385279035902827,0,0
OXIDATIVE PHOSPHORYLATION,Endothelial Lymphatic LYVE1,-0.292073138342093,0,0
OXIDATIVE PHOSPHORYLATION,Endothelial RGS5,0.274775150633363,0,0
OXIDATIVE PHOSPHORYLATION,Luminal Progenitors,-0.370985578996881,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Macrophage,0.316592649033856,0,0
OXIDATIVE PHOSPHORYLATION,Mature Luminal,-0.465005693396633,NA,> 0.05
OXIDATIVE PHOSPHORYLATION,Monocyte,0.0921461473609728,0,0
OXIDATIVE PHOSPHORYLATION,Myoepithelial,-0.548003390906168,NA,> 0.05
OXIDATIVE PHOSPHORYLATION,NK cells,0.153192010561606,0,> 0.05
OXIDATIVE PHOSPHORYLATION,NKT cells,0.0562397915018229,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Plasmablasts,0.14889821336207,NA,> 0.05
OXIDATIVE PHOSPHORYLATION,PVL Differentiated,-0.237648792742791,0,> 0.05
OXIDATIVE PHOSPHORYLATION,PVL Immature,0.343476014572958,0,> 0.05
OXIDATIVE PHOSPHORYLATION,T cells CD4+,0.0834825680990724,1.4533318616462,0.00695236286274383
OXIDATIVE PHOSPHORYLATION,T cells CD8+,0.0496793835496899,0,> 0.05
P53 PATHWAY,B cells Memory,0.476464808838419,1.76017006818079,4.59257667670532e-07
P53 PATHWAY,B cells Naive,0.1707349077481,NA,> 0.05
P53 PATHWAY,CAFs MSC iCAF-like,-0.138384766463238,0,> 0.05
P53 PATHWAY,CAFs myCAF-like,0.22629091605751,1.70320390512038,0.000342064695809182
P53 PATHWAY,Cancer Basal SC,0.538167608222307,1.75550251103202,0.000247831178862727
P53 PATHWAY,Cancer Cycling,0.470294843202238,0,> 0.05
P53 PATHWAY,Cancer Her2 SC,0.236431807542757,0,> 0.05
P53 PATHWAY,Cancer LumA SC,0.226550765280588,NA,> 0.05
P53 PATHWAY,Cancer LumB SC,-0.018852036058925,0,> 0.05
P53 PATHWAY,Cycling PVL,0.77749742738944,0,> 0.05
P53 PATHWAY,Cycling T-cells,0.380660818440968,0,> 0.05
P53 PATHWAY,Cycling Myeloid,0.058828698794903,0,NS
P53 PATHWAY,DCs,0.0791422281811993,0,> 0.05
P53 PATHWAY,Endothelial ACKR1,-0.0124185738837455,0,0
P53 PATHWAY,Endothelial CXCL12,0.211277765557185,0,0
P53 PATHWAY,Endothelial Lymphatic LYVE1,-0.373405509580667,0,0
P53 PATHWAY,Endothelial RGS5,0.117797926612908,0,0
P53 PATHWAY,Luminal Progenitors,-0.247833471229694,0,> 0.05
P53 PATHWAY,Macrophage,0.272335949361167,0,0
P53 PATHWAY,Mature Luminal,-0.487232787470704,NA,> 0.05
P53 PATHWAY,Monocyte,0.259025531996198,0,0
P53 PATHWAY,Myoepithelial,-0.232199133610877,NA,> 0.05
P53 PATHWAY,NK cells,0.331480166412182,0,> 0.05
P53 PATHWAY,NKT cells,0.513774161530706,0,> 0.05
P53 PATHWAY,Plasmablasts,0.125928038098495,NA,> 0.05
P53 PATHWAY,PVL Differentiated,0.435856453741112,0,> 0.05
P53 PATHWAY,PVL Immature,0.0610135221144332,0,> 0.05
P53 PATHWAY,T cells CD4+,0.470368618768577,1.59748792009452,0.000151427543199336
P53 PATHWAY,T cells CD8+,0.406444633591155,1.52556642630303,0.00208585148646704
PANCREAS BETA CELLS,B cells Memory,0.327365440963736,0,> 0.05
PANCREAS BETA CELLS,B cells Naive,-0.31790990497392,NA,> 0.05
PANCREAS BETA CELLS,CAFs MSC iCAF-like,-0.201588752321003,0,> 0.05
PANCREAS BETA CELLS,CAFs myCAF-like,-0.263964900656713,0,> 0.05
PANCREAS BETA CELLS,Cancer Basal SC,0.0739197601971184,0,> 0.05
PANCREAS BETA CELLS,Cancer Cycling,0.0422678600520761,0,> 0.05
PANCREAS BETA CELLS,Cancer Her2 SC,0.101570185450659,0,> 0.05
PANCREAS BETA CELLS,Cancer LumA SC,0.0273683409342573,NA,> 0.05
PANCREAS BETA CELLS,Cancer LumB SC,-0.0100575660206903,0,> 0.05
PANCREAS BETA CELLS,Cycling PVL,0.171753718293316,0,> 0.05
PANCREAS BETA CELLS,Cycling T-cells,-0.136538901556281,0,> 0.05
PANCREAS BETA CELLS,Cycling Myeloid,-0.201380183551774,0,NS
PANCREAS BETA CELLS,DCs,0.208013447087938,0,> 0.05
PANCREAS BETA CELLS,Endothelial ACKR1,0.240891453882031,0,0
PANCREAS BETA CELLS,Endothelial CXCL12,0.0622605215735721,0,0
PANCREAS BETA CELLS,Endothelial Lymphatic LYVE1,0.00745261278845427,0,0
PANCREAS BETA CELLS,Endothelial RGS5,0.144834000033442,0,0
PANCREAS BETA CELLS,Luminal Progenitors,0.0796977781814058,0,> 0.05
PANCREAS BETA CELLS,Macrophage,0.207274193631849,0,0
PANCREAS BETA CELLS,Mature Luminal,-0.487669186525691,NA,> 0.05
PANCREAS BETA CELLS,Monocyte,0.383574017242497,0,0
PANCREAS BETA CELLS,Myoepithelial,-0.380201262769075,NA,> 0.05
PANCREAS BETA CELLS,NK cells,-0.0671849740523324,0,> 0.05
PANCREAS BETA CELLS,NKT cells,-0.548331209298238,0,> 0.05
PANCREAS BETA CELLS,Plasmablasts,-0.0313913325764628,NA,> 0.05
PANCREAS BETA CELLS,PVL Differentiated,-0.455513509559045,0,> 0.05
PANCREAS BETA CELLS,PVL Immature,-0.0253132969272257,0,> 0.05
PANCREAS BETA CELLS,T cells CD4+,-0.0661695430827424,0,> 0.05
PANCREAS BETA CELLS,T cells CD8+,-0.101635786009725,0,> 0.05
PEROXISOME,B cells Memory,0.450535349679059,0,> 0.05
PEROXISOME,B cells Naive,-0.208913232223156,NA,> 0.05
PEROXISOME,CAFs MSC iCAF-like,0.0563200639097884,0,> 0.05
PEROXISOME,CAFs myCAF-like,-0.271440081076181,0,> 0.05
PEROXISOME,Cancer Basal SC,0.390474790860514,0,> 0.05
PEROXISOME,Cancer Cycling,0.257319127573179,0,> 0.05
PEROXISOME,Cancer Her2 SC,0.0726950940919927,0,> 0.05
PEROXISOME,Cancer LumA SC,0.248501920439845,NA,> 0.05
PEROXISOME,Cancer LumB SC,0.0307974505523902,0,> 0.05
PEROXISOME,Cycling PVL,0.856174166466844,0,> 0.05
PEROXISOME,Cycling T-cells,0.382370906144811,0,> 0.05
PEROXISOME,Cycling Myeloid,0.337309356152873,0,NS
PEROXISOME,DCs,0.40700024201957,0,> 0.05
PEROXISOME,Endothelial ACKR1,-0.277142083689927,0,0
PEROXISOME,Endothelial CXCL12,-0.157256582225117,0,0
PEROXISOME,Endothelial Lymphatic LYVE1,-0.0625121266356043,0,0
PEROXISOME,Endothelial RGS5,0.0156074926314344,0,0
PEROXISOME,Luminal Progenitors,-0.134710741023892,0,> 0.05
PEROXISOME,Macrophage,0.451037883462283,0,0
PEROXISOME,Mature Luminal,-0.397444868419417,NA,> 0.05
PEROXISOME,Monocyte,0.637135577312711,0,0
PEROXISOME,Myoepithelial,-0.258173404679495,NA,> 0.05
PEROXISOME,NK cells,0.158828642422753,0,> 0.05
PEROXISOME,NKT cells,0.285654034671526,0,> 0.05
PEROXISOME,Plasmablasts,0.0284757371929435,NA,> 0.05
PEROXISOME,PVL Differentiated,-0.669120756316824,0,> 0.05
PEROXISOME,PVL Immature,-0.0831561102384231,0,> 0.05
PEROXISOME,T cells CD4+,0.379562156515016,0,> 0.05
PEROXISOME,T cells CD8+,0.279562499716694,0,> 0.05
PI3K AKT MTOR SIGNALING,B cells Memory,0.33330665978798,0,> 0.05
PI3K AKT MTOR SIGNALING,B cells Naive,-0.109449386353128,NA,> 0.05
PI3K AKT MTOR SIGNALING,CAFs MSC iCAF-like,0.715768493383171,1.63501752715388,0.0125344260649185
PI3K AKT MTOR SIGNALING,CAFs myCAF-like,0.761956116752547,1.93644441851403,0.000128606141530485
PI3K AKT MTOR SIGNALING,Cancer Basal SC,0.300974679526714,0,> 0.05
PI3K AKT MTOR SIGNALING,Cancer Cycling,0.425694490145356,0,> 0.05
PI3K AKT MTOR SIGNALING,Cancer Her2 SC,0.0790461059924853,0,> 0.05
PI3K AKT MTOR SIGNALING,Cancer LumA SC,0.142789487183268,NA,> 0.05
PI3K AKT MTOR SIGNALING,Cancer LumB SC,0.258251295983707,0,> 0.05
PI3K AKT MTOR SIGNALING,Cycling PVL,0.693863407768877,0,> 0.05
PI3K AKT MTOR SIGNALING,Cycling T-cells,0.522424580064062,0,> 0.05
PI3K AKT MTOR SIGNALING,Cycling Myeloid,0.203207733573861,0,NS
PI3K AKT MTOR SIGNALING,DCs,0.381340107097382,0,> 0.05
PI3K AKT MTOR SIGNALING,Endothelial ACKR1,0.367181877922194,0,0
PI3K AKT MTOR SIGNALING,Endothelial CXCL12,0.539318608487737,0,0
PI3K AKT MTOR SIGNALING,Endothelial Lymphatic LYVE1,-0.0886552600881078,0,0
PI3K AKT MTOR SIGNALING,Endothelial RGS5,0.422590445013689,0,0
PI3K AKT MTOR SIGNALING,Luminal Progenitors,0.421139944090937,0,> 0.05
PI3K AKT MTOR SIGNALING,Macrophage,0.531363264236393,0,0
PI3K AKT MTOR SIGNALING,Mature Luminal,-0.242393173687619,NA,> 0.05
PI3K AKT MTOR SIGNALING,Monocyte,0.701896987973067,0,0
PI3K AKT MTOR SIGNALING,Myoepithelial,-0.00456457707149332,NA,> 0.05
PI3K AKT MTOR SIGNALING,NK cells,0.192117862428937,0,> 0.05
PI3K AKT MTOR SIGNALING,NKT cells,0.282728402785026,0,> 0.05
PI3K AKT MTOR SIGNALING,Plasmablasts,0.0372060403712575,NA,> 0.05
PI3K AKT MTOR SIGNALING,PVL Differentiated,0.332719848220207,0,> 0.05
PI3K AKT MTOR SIGNALING,PVL Immature,0.538066220816139,0,> 0.05
PI3K AKT MTOR SIGNALING,T cells CD4+,0.367544594009764,1.42682414824488,0.0395477826031223
PI3K AKT MTOR SIGNALING,T cells CD8+,0.334297206749908,0,> 0.05
PROTEIN SECRETION,B cells Memory,0.262998299981739,1.67457450049765,0.00116615772873708
PROTEIN SECRETION,B cells Naive,-0.0852781536645194,NA,> 0.05
PROTEIN SECRETION,CAFs MSC iCAF-like,0.109241101071828,0,> 0.05
PROTEIN SECRETION,CAFs myCAF-like,0.549033515000429,1.79450453997437,0.0013629853281565
PROTEIN SECRETION,Cancer Basal SC,0.323888080736656,0,> 0.05
PROTEIN SECRETION,Cancer Cycling,0.356301275249003,0,> 0.05
PROTEIN SECRETION,Cancer Her2 SC,-0.229705148647207,0,> 0.05
PROTEIN SECRETION,Cancer LumA SC,0.138603665481227,NA,> 0.05
PROTEIN SECRETION,Cancer LumB SC,0.122382958874936,0,> 0.05
PROTEIN SECRETION,Cycling PVL,0.469561152971651,0,> 0.05
PROTEIN SECRETION,Cycling T-cells,-0.726960175796605,0,> 0.05
PROTEIN SECRETION,Cycling Myeloid,0.630485070972385,0,NS
PROTEIN SECRETION,DCs,0.40244466447161,0,> 0.05
PROTEIN SECRETION,Endothelial ACKR1,0.45996618926742,0,0
PROTEIN SECRETION,Endothelial CXCL12,0.434592914822492,0,0
PROTEIN SECRETION,Endothelial Lymphatic LYVE1,-0.153071056535244,0,0
PROTEIN SECRETION,Endothelial RGS5,0.585299192544377,0,0
PROTEIN SECRETION,Luminal Progenitors,-0.475681468195062,0,> 0.05
PROTEIN SECRETION,Macrophage,0.682858537097536,0,0
PROTEIN SECRETION,Mature Luminal,-0.438950202503588,NA,> 0.05
PROTEIN SECRETION,Monocyte,0.468299476757094,0,0
PROTEIN SECRETION,Myoepithelial,0.0626156404316476,NA,> 0.05
PROTEIN SECRETION,NK cells,-0.283638394602095,0,> 0.05
PROTEIN SECRETION,NKT cells,-0.747653416236519,0,> 0.05
PROTEIN SECRETION,Plasmablasts,0.132513524700407,NA,> 0.05
PROTEIN SECRETION,PVL Differentiated,0.158975087311579,0,> 0.05
PROTEIN SECRETION,PVL Immature,0.573414086158532,0,> 0.05
PROTEIN SECRETION,T cells CD4+,-0.120634117277322,0,> 0.05
PROTEIN SECRETION,T cells CD8+,-0.265611598330314,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,B cells Memory,0.456402704838031,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,B cells Naive,-0.226164228616333,NA,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,CAFs MSC iCAF-like,0.211658852403941,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,CAFs myCAF-like,0.292056778243535,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer Basal SC,0.528739277288398,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer Cycling,0.525398020943063,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer Her2 SC,0.0143669520325456,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer LumA SC,0.351034800933347,NA,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer LumB SC,0.468152105967806,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cycling PVL,0.71618646763238,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cycling T-cells,0.0986578007458996,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cycling Myeloid,0.348607103583447,0,NS
REACTIVE OXYGEN SPECIES PATHWAY,DCs,0.380228301361744,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Endothelial ACKR1,0.0206731244526636,0,0
REACTIVE OXYGEN SPECIES PATHWAY,Endothelial CXCL12,0.205353635459094,0,0
REACTIVE OXYGEN SPECIES PATHWAY,Endothelial Lymphatic LYVE1,0.322917293338037,0,0
REACTIVE OXYGEN SPECIES PATHWAY,Endothelial RGS5,0.140027455681985,0,0
REACTIVE OXYGEN SPECIES PATHWAY,Luminal Progenitors,0.0313985027763424,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Macrophage,0.28039514833989,0,0
REACTIVE OXYGEN SPECIES PATHWAY,Mature Luminal,-0.449050816068474,NA,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Monocyte,0.28802021704844,0,0
REACTIVE OXYGEN SPECIES PATHWAY,Myoepithelial,0.0790688746542623,NA,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,NK cells,0.288341826353392,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,NKT cells,0.484453385405152,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Plasmablasts,-0.0140929924947651,NA,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,PVL Differentiated,-0.0124520495948444,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,PVL Immature,0.146054251290111,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,T cells CD4+,0.445895440897599,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,T cells CD8+,0.32043075191628,0,> 0.05
SPERMATOGENESIS,B cells Memory,-0.154043710301834,0,> 0.05
SPERMATOGENESIS,B cells Naive,-0.208372751354347,NA,> 0.05
SPERMATOGENESIS,CAFs MSC iCAF-like,-0.418239769607866,0,> 0.05
SPERMATOGENESIS,CAFs myCAF-like,-0.743425155150575,0,> 0.05
SPERMATOGENESIS,Cancer Basal SC,-0.498462549653427,0,> 0.05
SPERMATOGENESIS,Cancer Cycling,0.104694970098968,0,> 0.05
SPERMATOGENESIS,Cancer Her2 SC,0.178897563582237,0,> 0.05
SPERMATOGENESIS,Cancer LumA SC,-0.211692826661665,NA,> 0.05
SPERMATOGENESIS,Cancer LumB SC,-0.194816314662728,0,> 0.05
SPERMATOGENESIS,Cycling PVL,-0.100532517585046,0,> 0.05
SPERMATOGENESIS,Cycling T-cells,0.751890250691323,0,> 0.05
SPERMATOGENESIS,Cycling Myeloid,0.460826117438483,0,NS
SPERMATOGENESIS,DCs,0.265654101256377,0,> 0.05
SPERMATOGENESIS,Endothelial ACKR1,-0.303575242317453,0,0
SPERMATOGENESIS,Endothelial CXCL12,-0.379747974926904,0,0
SPERMATOGENESIS,Endothelial Lymphatic LYVE1,-0.178297275799565,0,0
SPERMATOGENESIS,Endothelial RGS5,-0.0242632922739199,0,0
SPERMATOGENESIS,Luminal Progenitors,-0.205325039725341,0,> 0.05
SPERMATOGENESIS,Macrophage,-0.296245522913529,0,0
SPERMATOGENESIS,Mature Luminal,0.100360868485048,NA,> 0.05
SPERMATOGENESIS,Monocyte,-0.0714608245740361,0,0
SPERMATOGENESIS,Myoepithelial,0.546093448225188,NA,> 0.05
SPERMATOGENESIS,NK cells,0.0668067982787518,0,> 0.05
SPERMATOGENESIS,NKT cells,-0.042858017013952,0,> 0.05
SPERMATOGENESIS,Plasmablasts,0.0284293433625026,NA,> 0.05
SPERMATOGENESIS,PVL Differentiated,-0.451738190482248,0,> 0.05
SPERMATOGENESIS,PVL Immature,-0.463391763207635,0,> 0.05
SPERMATOGENESIS,T cells CD4+,0.0225476297856915,0,> 0.05
SPERMATOGENESIS,T cells CD8+,-0.0307479267344925,0,> 0.05
TGF BETA SIGNALING,B cells Memory,0.716319364180006,1.78174749258097,0.000519097968539804
TGF BETA SIGNALING,B cells Naive,-0.185774622409928,NA,> 0.05
TGF BETA SIGNALING,CAFs MSC iCAF-like,0.0638528508655966,0,> 0.05
TGF BETA SIGNALING,CAFs myCAF-like,0.492651959135427,0,> 0.05
TGF BETA SIGNALING,Cancer Basal SC,0.228053157792436,0,> 0.05
TGF BETA SIGNALING,Cancer Cycling,0.0681115376306259,0,> 0.05
TGF BETA SIGNALING,Cancer Her2 SC,0.154037277193769,0,> 0.05
TGF BETA SIGNALING,Cancer LumA SC,-0.265843129933425,NA,> 0.05
TGF BETA SIGNALING,Cancer LumB SC,-0.288521255729985,0,> 0.05
TGF BETA SIGNALING,Cycling PVL,0.172249554650275,0,> 0.05
TGF BETA SIGNALING,Cycling T-cells,0.505354465592932,0,> 0.05
TGF BETA SIGNALING,Cycling Myeloid,-0.00793613396791822,0,NS
TGF BETA SIGNALING,DCs,0.312845792346865,0,> 0.05
TGF BETA SIGNALING,Endothelial ACKR1,0.402962019172085,0,0
TGF BETA SIGNALING,Endothelial CXCL12,0.665339725731765,0,0
TGF BETA SIGNALING,Endothelial Lymphatic LYVE1,-0.189393678925733,0,0
TGF BETA SIGNALING,Endothelial RGS5,0.421340454737974,0,0
TGF BETA SIGNALING,Luminal Progenitors,0.191288084812199,1.75445708163616,0.0192335019855406
TGF BETA SIGNALING,Macrophage,0.355356942740283,0,0
TGF BETA SIGNALING,Mature Luminal,-0.0437434761170768,NA,> 0.05
TGF BETA SIGNALING,Monocyte,0.675295501164151,0,0
TGF BETA SIGNALING,Myoepithelial,-0.0315263024765665,NA,> 0.05
TGF BETA SIGNALING,NK cells,0.306422467464161,0,> 0.05
TGF BETA SIGNALING,NKT cells,0.263967047378359,0,> 0.05
TGF BETA SIGNALING,Plasmablasts,-0.141161287917049,NA,> 0.05
TGF BETA SIGNALING,PVL Differentiated,0.5788512144587,0,> 0.05
TGF BETA SIGNALING,PVL Immature,0.679666260438319,0,> 0.05
TGF BETA SIGNALING,T cells CD4+,0.56993606074465,0,> 0.05
TGF BETA SIGNALING,T cells CD8+,0.570526060267744,0,> 0.05
TNFA SIGNALING VIA NFKB,B cells Memory,0.570178176978055,2.27179028321494,7.13215574330184e-19
TNFA SIGNALING VIA NFKB,B cells Naive,0.199767938056962,NA,> 0.05
TNFA SIGNALING VIA NFKB,CAFs MSC iCAF-like,0.187935192566199,2.33714061922746,4.54397677750634e-11
TNFA SIGNALING VIA NFKB,CAFs myCAF-like,0.407471557395591,2.81726150453894,2.52903327519476e-18
TNFA SIGNALING VIA NFKB,Cancer Basal SC,0.305473805191994,2.27340097465277,3.05031830366461e-10
TNFA SIGNALING VIA NFKB,Cancer Cycling,0.175418863046245,2.17688174691034,8.26645556792984e-09
TNFA SIGNALING VIA NFKB,Cancer Her2 SC,0.192964586419857,1.92655602104593,3.49083730009003e-06
TNFA SIGNALING VIA NFKB,Cancer LumA SC,0.0347850876823512,NA,> 0.05
TNFA SIGNALING VIA NFKB,Cancer LumB SC,-0.483856567443466,1.71700161185614,0.000832402634589726
TNFA SIGNALING VIA NFKB,Cycling PVL,0.185792957455755,0,> 0.05
TNFA SIGNALING VIA NFKB,Cycling T-cells,0.25168133355907,0,> 0.05
TNFA SIGNALING VIA NFKB,Cycling Myeloid,0.103423185892019,0,NS
TNFA SIGNALING VIA NFKB,DCs,0.159899782510547,0,> 0.05
TNFA SIGNALING VIA NFKB,Endothelial ACKR1,0.153882676415018,0,0
TNFA SIGNALING VIA NFKB,Endothelial CXCL12,0.11232130121929,0,0
TNFA SIGNALING VIA NFKB,Endothelial Lymphatic LYVE1,-0.0122020136004531,0,0
TNFA SIGNALING VIA NFKB,Endothelial RGS5,0.0610278902825525,0,0
TNFA SIGNALING VIA NFKB,Luminal Progenitors,0.0235084981950161,0,> 0.05
TNFA SIGNALING VIA NFKB,Macrophage,0.18459099763713,0,0
TNFA SIGNALING VIA NFKB,Mature Luminal,-0.401305676176412,NA,> 0.05
TNFA SIGNALING VIA NFKB,Monocyte,0.151301939038377,0,0
TNFA SIGNALING VIA NFKB,Myoepithelial,0.0511548823973859,NA,> 0.05
TNFA SIGNALING VIA NFKB,NK cells,0.540894752953451,0,> 0.05
TNFA SIGNALING VIA NFKB,NKT cells,0.199053367329668,0,> 0.05
TNFA SIGNALING VIA NFKB,Plasmablasts,0.14824262670063,NA,> 0.05
TNFA SIGNALING VIA NFKB,PVL Differentiated,0.706630735891781,2.04234978421569,3.27710999946669e-10
TNFA SIGNALING VIA NFKB,PVL Immature,0.397149107779202,1.51849080385002,0.00659592663047713
TNFA SIGNALING VIA NFKB,T cells CD4+,0.61572006367402,1.87932243228638,4.9206498851311e-09
TNFA SIGNALING VIA NFKB,T cells CD8+,0.447283290985844,1.83230655472913,7.946513704386e-07
UNFOLDED PROTEIN RESPONSE,B cells Memory,0.200470973965363,0,> 0.05
UNFOLDED PROTEIN RESPONSE,B cells Naive,0.0320846811077339,NA,> 0.05
UNFOLDED PROTEIN RESPONSE,CAFs MSC iCAF-like,0.152191789616419,0,> 0.05
UNFOLDED PROTEIN RESPONSE,CAFs myCAF-like,0.242743364202305,1.59675585502827,0.0045171328933197
UNFOLDED PROTEIN RESPONSE,Cancer Basal SC,0.484527305441479,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cancer Cycling,0.670616515702239,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cancer Her2 SC,0.252601446084398,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cancer LumA SC,0.160200551505488,NA,> 0.05
UNFOLDED PROTEIN RESPONSE,Cancer LumB SC,0.208259067897082,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cycling PVL,0.719302498469659,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cycling T-cells,-0.0557305460661646,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cycling Myeloid,0.215925338460291,0,NS
UNFOLDED PROTEIN RESPONSE,DCs,0.552585314983376,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Endothelial ACKR1,0.151085018259268,0,0
UNFOLDED PROTEIN RESPONSE,Endothelial CXCL12,0.247063467648266,0,0
UNFOLDED PROTEIN RESPONSE,Endothelial Lymphatic LYVE1,-0.135980860888934,0,0
UNFOLDED PROTEIN RESPONSE,Endothelial RGS5,0.470440538161517,0,0
UNFOLDED PROTEIN RESPONSE,Luminal Progenitors,-0.167344657269822,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Macrophage,0.138012235770513,0,0
UNFOLDED PROTEIN RESPONSE,Mature Luminal,-0.313800108276425,NA,> 0.05
UNFOLDED PROTEIN RESPONSE,Monocyte,0.399599167820033,0,0
UNFOLDED PROTEIN RESPONSE,Myoepithelial,-0.147416285892765,NA,> 0.05
UNFOLDED PROTEIN RESPONSE,NK cells,0.332780031085544,0,> 0.05
UNFOLDED PROTEIN RESPONSE,NKT cells,0.578041367133654,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Plasmablasts,0.121192657649632,NA,> 0.05
UNFOLDED PROTEIN RESPONSE,PVL Differentiated,0.350335687218912,0,> 0.05
UNFOLDED PROTEIN RESPONSE,PVL Immature,0.0983959712960698,0,> 0.05
UNFOLDED PROTEIN RESPONSE,T cells CD4+,0.558425961519584,1.43924450052457,0.0181263986101124
UNFOLDED PROTEIN RESPONSE,T cells CD8+,0.413160360499339,0,> 0.05
UV RESPONSE DN,B cells Memory,0.22185942163557,0,> 0.05
UV RESPONSE DN,B cells Naive,-0.0431202335366363,NA,> 0.05
UV RESPONSE DN,CAFs MSC iCAF-like,0.0381217723420321,0,> 0.05
UV RESPONSE DN,CAFs myCAF-like,-0.0548906967291341,0,> 0.05
UV RESPONSE DN,Cancer Basal SC,0.439887893876054,2.15199697615168,2.9229589482013e-07
UV RESPONSE DN,Cancer Cycling,0.318600327050506,2.2510630119526,1.72311444096641e-08
UV RESPONSE DN,Cancer Her2 SC,0.431893995950315,2.24954446668668,2.41952780944918e-07
UV RESPONSE DN,Cancer LumA SC,0.189732915787756,NA,> 0.05
UV RESPONSE DN,Cancer LumB SC,-0.180336118028057,0,> 0.05
UV RESPONSE DN,Cycling PVL,0.469004803342416,0,> 0.05
UV RESPONSE DN,Cycling T-cells,0.293783820496755,0,> 0.05
UV RESPONSE DN,Cycling Myeloid,0.141181827583043,0,NS
UV RESPONSE DN,DCs,-0.0159928818021355,0,> 0.05
UV RESPONSE DN,Endothelial ACKR1,0.426085436406034,0,0
UV RESPONSE DN,Endothelial CXCL12,0.470511131613891,0,0
UV RESPONSE DN,Endothelial Lymphatic LYVE1,-0.398982844164021,0,0
UV RESPONSE DN,Endothelial RGS5,0.408433408894115,0,0
UV RESPONSE DN,Luminal Progenitors,0.559303947477152,0,> 0.05
UV RESPONSE DN,Macrophage,0.311065827758083,0,0
UV RESPONSE DN,Mature Luminal,0.182824790942699,NA,> 0.05
UV RESPONSE DN,Monocyte,0.14462750207362,0,0
UV RESPONSE DN,Myoepithelial,-0.0957540481873133,NA,> 0.05
UV RESPONSE DN,NK cells,0.431541644723394,0,> 0.05
UV RESPONSE DN,NKT cells,0.0987947080650793,0,> 0.05
UV RESPONSE DN,Plasmablasts,-0.0132926638783744,NA,> 0.05
UV RESPONSE DN,PVL Differentiated,0.434713343307533,0,> 0.05
UV RESPONSE DN,PVL Immature,0.241872240849385,0,> 0.05
UV RESPONSE DN,T cells CD4+,0.624694477713284,0,> 0.05
UV RESPONSE DN,T cells CD8+,0.543873721987757,0,> 0.05
UV RESPONSE UP,B cells Memory,0.63633229736911,1.48612075536426,0.00561623716874525
UV RESPONSE UP,B cells Naive,0.405384488000833,NA,> 0.05
UV RESPONSE UP,CAFs MSC iCAF-like,0.0129435661591486,0,> 0.05
UV RESPONSE UP,CAFs myCAF-like,0.291195953246253,0,> 0.05
UV RESPONSE UP,Cancer Basal SC,0.477288271765448,0,> 0.05
UV RESPONSE UP,Cancer Cycling,0.530197102952209,0,> 0.05
UV RESPONSE UP,Cancer Her2 SC,0.249767850673521,0,> 0.05
UV RESPONSE UP,Cancer LumA SC,0.129514468676701,NA,> 0.05
UV RESPONSE UP,Cancer LumB SC,-0.208494796615703,0,> 0.05
UV RESPONSE UP,Cycling PVL,0.30709220155774,0,> 0.05
UV RESPONSE UP,Cycling T-cells,0.570192116232494,0,> 0.05
UV RESPONSE UP,Cycling Myeloid,0.291322702578554,0,NS
UV RESPONSE UP,DCs,0.31269769386983,0,> 0.05
UV RESPONSE UP,Endothelial ACKR1,-0.0319407219913332,0,0
UV RESPONSE UP,Endothelial CXCL12,0.128161253328112,0,0
UV RESPONSE UP,Endothelial Lymphatic LYVE1,-0.265735294379675,0,0
UV RESPONSE UP,Endothelial RGS5,0.0985484113017925,0,0
UV RESPONSE UP,Luminal Progenitors,-0.0956058811426056,0,> 0.05
UV RESPONSE UP,Macrophage,0.293745505421055,0,0
UV RESPONSE UP,Mature Luminal,-0.362695399413131,NA,> 0.05
UV RESPONSE UP,Monocyte,0.287069108234485,0,0
UV RESPONSE UP,Myoepithelial,-0.0305590334088223,NA,> 0.05
UV RESPONSE UP,NK cells,0.351117630050354,0,> 0.05
UV RESPONSE UP,NKT cells,0.379003166127425,0,> 0.05
UV RESPONSE UP,Plasmablasts,0.0463099808560866,NA,> 0.05
UV RESPONSE UP,PVL Differentiated,0.500621385681371,0,> 0.05
UV RESPONSE UP,PVL Immature,0.173173970899195,0,> 0.05
UV RESPONSE UP,T cells CD4+,0.586103636772503,0,> 0.05
UV RESPONSE UP,T cells CD8+,0.484771793987369,1.51152290531245,0.0129466272609368
WNT BETA CATENIN SIGNALING,B cells Memory,0.0868625166202212,0,> 0.05
WNT BETA CATENIN SIGNALING,B cells Naive,0.107524543833517,NA,> 0.05
WNT BETA CATENIN SIGNALING,CAFs MSC iCAF-like,-0.108277466701158,0,> 0.05
WNT BETA CATENIN SIGNALING,CAFs myCAF-like,0.0868030356015717,0,> 0.05
WNT BETA CATENIN SIGNALING,Cancer Basal SC,0.0401245778547252,0,> 0.05
WNT BETA CATENIN SIGNALING,Cancer Cycling,0.0414443025018902,0,> 0.05
WNT BETA CATENIN SIGNALING,Cancer Her2 SC,0.224806091639401,0,> 0.05
WNT BETA CATENIN SIGNALING,Cancer LumA SC,-0.0703683197390946,NA,> 0.05
WNT BETA CATENIN SIGNALING,Cancer LumB SC,0.276044291018991,0,> 0.05
WNT BETA CATENIN SIGNALING,Cycling PVL,0.432439776258732,0,> 0.05
WNT BETA CATENIN SIGNALING,Cycling T-cells,-0.265810893362117,0,> 0.05
WNT BETA CATENIN SIGNALING,Cycling Myeloid,-0.505680182510273,0,NS
WNT BETA CATENIN SIGNALING,DCs,-0.497766791198883,0,> 0.05
WNT BETA CATENIN SIGNALING,Endothelial ACKR1,0.290568454800697,0,0
WNT BETA CATENIN SIGNALING,Endothelial CXCL12,0.284392423146681,0,0
WNT BETA CATENIN SIGNALING,Endothelial Lymphatic LYVE1,-0.0684135910697389,0,0
WNT BETA CATENIN SIGNALING,Endothelial RGS5,0.106636935103926,0,0
WNT BETA CATENIN SIGNALING,Luminal Progenitors,-0.549027271081703,0,> 0.05
WNT BETA CATENIN SIGNALING,Macrophage,-0.254531856492697,0,0
WNT BETA CATENIN SIGNALING,Mature Luminal,0.484381074795478,NA,> 0.05
WNT BETA CATENIN SIGNALING,Monocyte,-0.316707162971211,0,0
WNT BETA CATENIN SIGNALING,Myoepithelial,-0.105487939207326,NA,> 0.05
WNT BETA CATENIN SIGNALING,NK cells,-0.215561013144684,0,> 0.05
WNT BETA CATENIN SIGNALING,NKT cells,-0.231547884331335,0,> 0.05
WNT BETA CATENIN SIGNALING,Plasmablasts,-0.0353254518893591,NA,> 0.05
WNT BETA CATENIN SIGNALING,PVL Differentiated,0.399084297588079,0,> 0.05
WNT BETA CATENIN SIGNALING,PVL Immature,-0.132958993340416,0,> 0.05
WNT BETA CATENIN SIGNALING,T cells CD4+,-0.488380309253954,0,> 0.05
WNT BETA CATENIN SIGNALING,T cells CD8+,-0.241879265776785,0,> 0.05
XENOBIOTIC METABOLISM,B cells Memory,0.251123829490067,0,> 0.05
XENOBIOTIC METABOLISM,B cells Naive,-0.0948782593673222,NA,> 0.05
XENOBIOTIC METABOLISM,CAFs MSC iCAF-like,-0.201075640816261,0,> 0.05
XENOBIOTIC METABOLISM,CAFs myCAF-like,-0.373506080871863,0,> 0.05
XENOBIOTIC METABOLISM,Cancer Basal SC,0.43716794419204,0,> 0.05
XENOBIOTIC METABOLISM,Cancer Cycling,0.498117284190999,0,> 0.05
XENOBIOTIC METABOLISM,Cancer Her2 SC,-0.05982055656357,0,> 0.05
XENOBIOTIC METABOLISM,Cancer LumA SC,0.167017077051032,NA,> 0.05
XENOBIOTIC METABOLISM,Cancer LumB SC,0.469467615050889,0,> 0.05
XENOBIOTIC METABOLISM,Cycling PVL,0.388287765576781,0,> 0.05
XENOBIOTIC METABOLISM,Cycling T-cells,-0.1343148344062,0,> 0.05
XENOBIOTIC METABOLISM,Cycling Myeloid,-0.0186979087430339,0,NS
XENOBIOTIC METABOLISM,DCs,0.118049505198586,0,> 0.05
XENOBIOTIC METABOLISM,Endothelial ACKR1,-0.0641893913230351,0,0
XENOBIOTIC METABOLISM,Endothelial CXCL12,-0.360085140416841,0,0
XENOBIOTIC METABOLISM,Endothelial Lymphatic LYVE1,-0.558308331152378,0,0
XENOBIOTIC METABOLISM,Endothelial RGS5,-0.226577140822745,0,0
XENOBIOTIC METABOLISM,Luminal Progenitors,-0.490260119756182,0,> 0.05
XENOBIOTIC METABOLISM,Macrophage,0.335027149888511,0,0
XENOBIOTIC METABOLISM,Mature Luminal,-0.507289313799968,NA,> 0.05
XENOBIOTIC METABOLISM,Monocyte,0.444352204644975,0,0
XENOBIOTIC METABOLISM,Myoepithelial,-0.308666543542265,NA,> 0.05
XENOBIOTIC METABOLISM,NK cells,0.0711680967189528,0,> 0.05
XENOBIOTIC METABOLISM,NKT cells,-0.140170059322314,0,> 0.05
XENOBIOTIC METABOLISM,Plasmablasts,-0.240860676211485,NA,> 0.05
XENOBIOTIC METABOLISM,PVL Differentiated,0.159988836337445,0,> 0.05
XENOBIOTIC METABOLISM,PVL Immature,0.0268109759136197,0,> 0.05
XENOBIOTIC METABOLISM,T cells CD4+,-0.264423268224699,0,> 0.05
XENOBIOTIC METABOLISM,T cells CD8+,-0.31976262600241,0,> 0.05
